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The skin forms a critical barrier against the external environment and is therefore frequently 
challenged by infections and subjected to immune-mediated diseases as well as malignancies. 
The Tissue-Resident Memory T (TRM) cell is a subset of T cells that resides at sites of 
previous infection in the skin and other epithelial tissues. Upon re-activation, TRM cells 
provide rapid, robust and localized adaptive immune defence against re-infection. The role of 
TRM cells in different human diseases is increasingly appreciated. This thesis aims to explore 
the functional capacity and regulatory mechanisms of resident T cells in human skin and their 
potential roles in two different immune-mediated skin diseases, vitiligo and psoriasis.  
PAPER I: Human skin contains heterogeneous populations of T cells. CD49a expression 
marks a functionally distinct subpopulation of epidermal CD8 TRM cells that are highly 
poised towards IFN-γ production and cytolytic function, whereas CD49a- TRM cells 
preferentially produced IL-17. The cytotoxic potential of CD49a+ TRM cell was specifically 
unleashed by IL-15 stimulation. In vitiligo, an acquired chronic depigmenting disorder of the 
skin, CD49a+ TRM cells accumulated in both epidermis and dermis in lesions implicating a 
pathogenic role of CD49a+ TRM cells.  
PAPER II: In psoriasis, a common chronic inflammatory skin disease, a large proportion of 
epidermal T cells, but not dermal T cells, expressed the pathogenic cytokines IL-17 and IL-22 
during active disease (PAPER II). Upon clinical remission, T cells with pathogenic capacity 
were retained in the epidermis of resolved lesions. Upon reactivation, CD4 T cells responded 
with IL-22 production, whereas CD8 T cells with TRM cell phenotypes responded with IL-17. 
A model of localized disease memory based on TRM cells in resolved psoriasis was proposed.  
PAPER III: CD8 T cells in active psoriasis lesions expressed granzyme A, but not granzyme 
B or perforin. In vitro experiments showed that granzyme A specifically promotes chemokine 
expression in IL-17 stimulated keratinocytes. Thus, granzyme A expression in skin-resident 
CD8 T cells may provide proinflammatory signals in psoriasis. 
PAPER IV: In cohorts of Caucasian psoriasis patients and healthy controls, genetic 
association of variants within IL22 promoter is confined to patients with disease on-set before 
puberty. The risk haplotype of the IL22 promoter led to higher transcriptional activity and 
higher IL-22 production in CD4 T cells from psoriasis patients, underscoring the impact of 
genetic heterogeneity and their functional consequences in immune-mediated skin diseases.  
Through characterization of resident T cells in human skin in healthy and inflammatory 
conditions, this thesis demonstrates the functional heterogeneity of skin-resident T cells in 
healthy skin, vitiligo and psoriasis. Further understanding of the formation, homeostatic, 
regulatory and effector mechanisms of TRM cell may unveil novel therapeutic strategies and 
improve disease management in a wide range of skin conditions. 
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1 INTRODUCTION 
The immune system protects multicellular-organisms from infections. In higher vertebrates 
the immune system is classically divided into two major subsystems: the innate and adaptive 
immune systems.  
The innate immune system provides rapid response to pathogens but has limited specificity. 
Innate immune cells include granulocytes, macrophages, dendritic cells and innate lymphoid 
cells. Despite limited specificity, each type of innate immune cells has a specialized function: 
engulfing pathogens or dying cells (neutrophils, macrophages, dendritic cells), secreting 
inflammatory mediators and enzymes (mast cells, basophils and eosinophils), killing of 
aberrant cells (natural killer cells) and presenting antigens to helper T cells (macrophages, 
dendritic cells). In broad terms, most cells in the body possess various degrees of innate 
immune function. Epithelial cells that form the border of the body are particularly important 
in providing the first line of innate immune defense, and therefore, could also be considered 
as part of the innate immune system. The adaptive immune system targets pathogens with 
specificity and is characterised by the formation of immunologic memory. B lymphocytes (B 
cells) and T lymphocytes (T cells) are the primary cell types responsible for establishing 
adaptive immunity, in which B cells mediate humoral immunity by producing antibodies; 
whilst T cells mediate cellular immunity through helping other immune cell types or targeted 
killing of virally infected cells (Kindt et al., 2007; Abbas and Lichtman, 2011; Murphy et al., 
2012). 
The skin is one of the largest interfaces between the body and outer environments. It requires 
immune defense against various forms of insult and violation. In this regard, the skin is a 
crucial part of the immune system, sensing and responding to foreign entities. Such immune-
surveillance is established by both the innate and adaptive immune cells. T cells in particular 
can be recruited to the skin during active inflammation. Recently, resident T cells were 
shown to establish on-site adaptive immunity in the skin after virus infection, providing the 
first line of adaptive immune defense against re-infection (Gebhardt et al., 2009; Jiang et al., 
2012). However, T cells also play key pathogenic roles in many skin diseases. Complex 
interactions between genetic susceptibility and environmental triggers may result in an over-
reaction of immune responses that could cause unwanted inflammation leading to tissue 
destruction, autoimmunity or inflammatory diseases. In vitiligo, auto-reactive T cells may 
cause disappearance of melanocytes in the skin, resulting in loss of skin pigments. In 
psoriasis, hyper-inflammatory T cells in skin help to sustain chronic inflammation. Although 
effective treatments are available for psoriasis, local relapse is still a major therapeutic 
challenge and a "molecular scar" of psoriasis have been proposed (Suárez-Fariñas et al., 
2011). 
Through characterizing the resident T cells in human skin, this thesis aims to uncover their 
functional heterogeneity and explore their roles in two chronic immune-mediated skin 
diseases, psoriasis and vitiligo.  
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2 T CELLS 
T cells are lymphocytes that play a central role in establishing and maintaining cellular 
adaptive immunity in vertebrates. A T cell, which has gone through the maturation process in 
thymus, expresses a clonotype of functional T cells receptor (TCR) on its surface. In the past 
few decades, various subsets of T cells have been identified and classified by their functional 
capacities. The T cell population can be subdivided into two main categories, the 
“conventional” T cells and the “unconventional” T cells. The former recognize peptide 
antigens bound onto classical Major Histocompatibility Complex (MHC) molecules with 
their TCR αβ chain; whereas the latter, such as γδT cells, Natural Killer T (NKT) cells and 
Mucosal-associated invariant T (MAIT) cells, recognize antigens presented by other 
molecules, like Cluster of differentiation (CD)1a-d or MHC related protein-1(MR1) 
molecules (Godfrey et al., 2015).  
2.1 T Cell – the Overture 
One of the classical characteristics of adaptive immunity is the ability to mount specific 
responses against foreign antigens, while limiting auto-reactivity by distinguishing self from 
non-self. Conventional T cells achieve this through the self-restricted interaction between 
their membrane-bound αβ chains of the T cell receptor (TCR) and peptide bound to the self-
MHC- molecule expressed on the target cells or antigen presenting cells. The αβ chains of 
TCR form the functional TCR complex together with the CD3 molecules, which relay the 
downstream signaling (Smith-Garvin et al., 2009). 
2.1.1 T Cell Selection - The Making of a Mature but Naïve T cell 
The huge diversity of T cell receptor (TCR) within a single individual is generated by V-(D)-
J recombination, which is a form of somatic DNA rearrangement that takes place in the 
thymus (Schatz and Swanson, 2011). This process provides the molecular basis for 
recognizing numerous antigens. Productive 
recombination of the TCR gene results from the 
joining of the V (Variable) and J (Joining) segments 
in the α chain, and the V, D (Diversity) and J 
segments in the β chain (Figure 2.1).  The most 
variable parts of each chain of TCR are the three 
Complementarity Determining Regions (CDRs). The 
CDR1 and CDR2 are determined by the sequence of 
the V segment; the CDR3 is the junction between V, 
(D), and J segments. Random addition or deletion 
during recombination adds further variability to 
CDR3, making it the most variable region of the 
TCR (Siu et al., 1984; Schatz and Swanson, 2011; 
Attaf et al., 2015). 
Figure 2.1. V(D)J rearrangement of T 
cells , Adaptation of (Attaf et al., 2015)  
  9 
It has been estimated that V-(D)-J recombination can theoretically generate ~ 1018 TCR 
clonotypes in humans and ~ 1015  in mice (Davis and Bjorkman, 1988; Attaf et al., 2015). 
However, the estimated size of T cell repertoire is much smaller (< 108) than the theoretical 
value (Arstila et al., 1999; Robins et al., 2010). This is due to several factors. First, carrying 
>1018 T cells with unique TCRs within a human body would be biologically infeasible. 
Secondly, a large number of the possible recombined TCRs would not recognize self-MHC 
and would not be functional. Thirdly, some of the TCRs may recognize self-antigens 
strongly, potentially causing autoimmunity. According to the classical affinity model of 
thymic selection for conventional T cells, T cells bearing functional TCR with a relatively 
low affinity to self-peptides presented on self-MHC molecules will be released to the 
circulation; whereas T cells with a non-functional or non-self-restrictive TCR and T cells 
bearing TCR with high affinity to self-peptide:MHC will be eliminated (Klein et al., 2014). 
However, the assumption of the absolute specificity of TCR implies that a lot of potential 
foreign peptides cannot be detected (Mason, 1998). It has been postulated and later supported 
by experimental data that a single TCR may cross-react with numerous of different peptides 
presented on self-MHC, filling the gap in the unmatched foreign peptide diversity (Mason, 
1998; Sewell, 2012; Wooldridge et al., 2012). Together, these features warrant the self-
restriction nature of the TCR:MHC interaction and provide the basis for detecting foreign 
antigens, whilst limiting the chance of autoimmunity. 
2.1.2 T Cell Activation 
After the thymic selection, extrathymic T cells are “mature” but “naïve” (Sprent and Tough, 
1994). Naïve T cells circulate through secondary lymphoid organs. In case of an infection, the 
pathogen-specific naïve T cells can be activated by antigen presenting cells in secondary 
lymphoid tissues and expand, eventually differentiating into effector and memory T cells 
(Sprent and Tough, 1994). Dendritic cells (DCs), amongst the professional antigen presenting 
cells, can migrated to or resided in lymph nodes, providing potent activation to T cells. 
However, MHC:TCR ligation alone does not result in full activation of naïve T cells. A 
second stimulus is required in the form of co-stimulation, as exemplified by the co-
stimulatory molecule CD28. Downstream signals of CD28 induce expression of interleukin 
(IL)-2 that promote clonal expansion and survival of T cells (Sharpe and Freeman, 2002). On 
the other hand, co-inhibitory signals, such as cytotoxic T-lymphocyte-associated protein-4 
(CTLA4) and Programmed cell death-1 (PD-1), limit the scale of T cell-mediated immune 
response (Sharpe and Freeman, 2002). Cytokine stimulation from antigen presenting cells is 
considered as the third signal required for T cell activation (Curtsinger and Mescher, 2010) 
that determines the functional fate of the T cells upon activation (see the section below). 
2.2 Conventional T Cell Subsets 
Two major types of conventional αβ T cells are classified by their expression of co-receptor 
CD4 or CD8. CD4 T cells recognize peptides presented by MHC class II molecules, which 
are expressed on professional antigen presenting cells. Activated CD4 T cells mediate their 
effector functions through cytokine production. On the contrary, CD8 T cells recognize 
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peptides bound on MHC class I molecules expressed on most cell types. And in addition to 
cytokine production, these cells are specialized in killing of target cells. 
2.2.1 CD4 T Cell – The Helper 
Depending on the cytokine expression after activation, CD4 T cells can be classified into 
different T helper (Th) subsets. As early as in the 1980s, Mosmann and Coffman showed that 
there were at least two types of T helper cell clones from mice, distinguished by cytokine 
expression (Mosmann et al., 1986; Mosmann and Coffman, 1989). These two subsets were 
termed Th1 that produced interferon (IFN)-γ and IL-2, and Th2 that produced IL-4 (then 
known as B cell stimulating factor 1, BSF-1) (Mosmann et al., 1986). It was later determined 
that Th2 produced mainly IL-4, IL-5 and IL-13 which were critical for IgE production and 
clearance of extracellular parasites by enhancing function of eosinophils (Ansel et al., 2006; 
Zhu et al., 2010). On the other hand, Th1 produced high level of IFN-γ and were instrumental 
in inducing macrophages phagocytosis and cellular cytotoxicity, which were essential in 
clearing intracellular pathogens (Mosmann and Coffman, 1989; Szabo et al., 2003). The 
importance of this functional dichotomy was illustrated by murine cutaneous Leishmania 
infection where a resistant mouse strain (C57BL/6) imposes an effective Th1 response 
towards the parasites, whereas the susceptible strain (BALB/c) responses with Th2 
inflammation that fail to constrain the infection, leading to chronic infection (Locksley et al., 
1987; Heinzel et al., 1989). In the mid-2000s, a third subset of helper T cells was proposed as 
Th17, which was characterized by its expression of IL-17 (Harrington et al., 2005; Langrish, 
2005; Park et al., 2005). Although being named Th17, these cells produce not only IL-17 but 
also IL-21, IL-22 or IL-26 (Korn et al., 2009). A wide-range of extracellular pathogens, 
including Candida and Streptococcus, can trigger Th17 response (Korn et al., 2009; Zielinski 
et al., 2012). Since its discovery, the Th17 cell has been found to be potent inducers of 
autoimmune tissue inflammation and implicated in many inflammatory diseases, such as 
multiple sclerosis, rheumatoid arthritis and psoriasis (Huang et al., 2004; Hirota et al., 2007a; 
Hirota et al., 2007b; Lowes et al., 2008; Korn et al., 2009). In addition, a population of IL-22 
producing T cells without IL-17 production is sometime designated as Th22, and has been 
shown to play a role in epithelial homeostasis (Duhen et al., 2009; Eyerich et al., 2009). 
The development and transcriptional regulations of different Th subsets have been studied 
extensively in recent years. Soon after the discovery of distinct cytokine production patterns 
in different Th subsets, it became clear that specific sets of cytokines were crucial in Th 
subsets differentiation. Each of these Th subsets can also be defined by their expression of 
lineage defining transcriptional regulators, inducing or suppressing the expression of various 
sets of genes (Figure 2.2). IL-12 and IFN-γ, in particular, are important in Th1 differentiation 
with the lineage defining transcriptional factor T-bet; similarly, IL-4 and the expression of 
GATA3 are crucial for Th2 differentiation (Szabo et al., 2003; Ansel et al., 2006; Zhu et al., 
2010). For Th17, RORγT was identified as the lineage defining transcriptional factor, and 
combinations of Transforming Growth Factor (TGF) β, IL-1β, IL-6, IL-21, and IL-23 induce 
differentiation of Th17 (Korn et al., 2009). 
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The regulatory T cell (Treg) is another member of the CD4 T cell family. In contrast to other 
subsets described above, Treg is characterized by its suppressive function in immune 
responses. In the mid-1990s, Sakaguchi et al. showed that transfer of CD25+ CD4 T cells 
could attenuate allogenic response towards skin grafts and suggested CD25 as a marker for 
Tregs (Sakaguchi et al., 1995).  Foxp3 was subsequently identified as the master 
transcriptional regulator for Treg (Hori et al., 2003) following the discovery that FOXP3 
mutation is the underlying cause for IPEX (immunodysregulation polyendocrinopathy 
enteropathy X-linked) syndrome in humans and the scruffy phenotype in mice (Bennett et al., 
2001; Wildin et al., 2001). FOXP3 deficiency in humans and mice led to the development of 
multiple inflammatory disorders (Bennett et al., 2001; Wildin et al., 2001). Tregs exert the 
suppressive function through multiple mechanisms, such as secretion of suppressive 
cytokines (TGFβ, IL-10), or by inducing tolerogenic antigen presenting cells (Shevach, 
2009).  
Classification of Th cells by means of effector cytokine production helps to understand how 
the immune system respond to different pathogens with tailor-made responses. However, 
their functional distinction is not always fixed (Cosmi et al., 2013; Geginat et al., 2014). 
Th17 cells seemed to be particularly unstable that could shift to Th1 (Annunziato et al., 2007; 
Lee et al., 2009), whereas Th1 cells could become IL-10 producing cells and limit 
inflammatory responses (Cope et al., 2011). These examples demonstrate the functional 
plasticity of CD4 T cells.  
2.2.2 CD8 T Cell – The Killer 
Activated CD8 T cells are usually called cytotoxic T lymphocytes (CTLs). Distinct from their 
CD4 counterpart, CD8 T cells have a more specific role in immune defense: killing of 
infected or aberrant cells. Upon activation, CD8 T cells up-regulate perforin and granzymes, 
which are proteins stored in cytotoxic granules responsible for cellular cytotoxicity. When 
encountering a virally infected cell, antigen-specific cytotoxic T cell degranulates, and the 
cytotoxic granule constituents are released through the immunological synapse (Voskoboinik 
et al., 2015). Perforin forms holes on target cells, allowing granzymes to enter target cells and 
Figure 2.2 CD4 T helper subsets. 
Adopted and modified 
 (Di Cesare et al., 2009) 
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induce apoptosis by activating the caspase pathway or the mitochondrial cell death pathway 
(Masson and Tschopp, 1985; Young et al., 1986; Talanian et al., 1997; Heibein et al., 2000; 
Sutton et al., 2000). Among the granzymes, a family of serine proteases stored in cytotoxic 
granules, granzyme B has a clear cytotoxic role and rapidly induce apoptosis via a caspase-
dependent pathway (Voskoboinik et al., 2015). In contrast, the role of granzyme A in 
mediating target cell apoptosis remains controversial (Lieberman and Fan, 2003; Metkar et 
al., 2008; Trapani and Bird, 2008; Susanto et al., 2013). Granzyme A-mediated killing of 
target cells takes longer time, requires much higher concentration, and may act through 
cleavage of nuclear proteins leading to DNA damages (Lieberman and Fan, 2003; Metkar et 
al., 2008). Other evidence suggested granzyme A alongside with granzyme M and K could 
act as proinflammatory proteases (Metkar et al., 2008; Voskoboinik et al., 2015; Wensink et 
al., 2015). In addition, granulysin, another cytotoxic granule protein, possesses bactericidal 
activity (Linde et al., 2005). CD8 T cells are also an important source of proinflammatory 
cytokines, in particular, IFN-γ, IL-2, and Tumor Necrosis Factor (TNF). CD8 T cells 
producing IL-4, IL-13 and IL-17 have also been identified (Geginat et al., 2003; Yen et al., 
2009); and are sometimes classified based on cytokine productions, paralleling the 
classification of Th subsets, i.e. Tc1, Tc2, and Tc17. 
2.3 T Cell Memory 
Developing antigen-specific immunologic memory is the hallmark of adaptive immunity. 
Together with recall antibody responses, memory T cells form long-term adaptive 
immunologic defense against pathogens. Once naïve T cells receive sufficient initial 
activation by pathogen antigen recognition, co-stimulation, and appropriate cytokine 
stimulation, they undergo rapid clonal expansion and most become effector cells. After 
pathogens are eradicated, most of the effector cells die in the contraction phase, but a small 
population of antigen-specific memory T cells persists for long time in the absence of cognate 
antigens. Upon re-exposure to the same pathogen, memory T cells mount a more rapid, 
robust and effective recall response; thereby, providing an augmented immunologic 
protection (Figure 2.3) (Williams and Bevan, 2007). 
 
Figure 2.3. Kinetics of T cells activation and immunologic memory. 
Adapted and modified from (Williams and Bevan, 2007) and (Jameson and Masopust, 2009). 
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2.3.1 Memory T Cell Subsets 
The pool of memory T cells includes T cell subsets of different functional capacity that 
preferentially recirculate or reside in different tissues in the body. In humans, CD45RO and 
CD45RA display reciprocal expression in the T cell population. CD45RO+ cells were initially 
ascribed as memory T cells and CD45RA+ cells as naïve cells due to their difference in 
functional capability (Akbar et al., 1988; Byrne et al., 1988). But it was later found that 
CD45RA also marked an effector-like population in CD27- CD8 T cells (Hamann et al., 
1997). Sallusto and colleagues further showed that memory cells could be sub-grouped. 
CCR7 and CD62L expression marked a subset of CD45RO+ memory cells, coined central 
memory T (TCM) cells (Sallusto et al., 1999), which recirculate to secondary lymphoid 
organs, such as lymph nodes. Another subset lacking CCR7 and CD62L expression was 
shown to have a higher cytokine production capacity and perforin expression; thus, it was 
termed the effector memory T (TEM) cells (Sallusto et al., 1999). TEM cells have been 
postulated to patrol through non-lymphoid tissues. Indeed, a majority of T cells in peripheral 
tissue are phenotypically and functionally similar to TEM cells (Campbell et al., 2001; 
Masopust, 2001; Reinhardt et al., 2001). Functionally, as compared to TCM cell, TEM cell 
display less proliferative potential upon antigenic stimulation (Geginat et al., 2003) and 
express higher level of perforin or granzymes (Takata and Takiguchi, 2006; Romero et al., 
2007). An effector-like TEM cell subset expressing CD45RA (sometimes depicted as TEMRA) 
constitutively expressed cytotoxic granule constituents, and had superior cytotoxic capacity; 
resembling terminally differentiated cells (Sallusto et al., 1999; Geginat et al., 2003). 
Therefore, apart from preferential homing destinations, the classification of memory 
phenotype can distinguish the readiness of cytokine production and cytolytic function of T 
cells under steady state. 
2.3.2 Tissue Resident Memory T cells 
The TCM / TEM model of memory T cell provided a theoretical framework of T cell 
immunologic memory that combined the functional specialization of T cell with their 
migration and localization pattern (Sallusto et al., 1999). However, this simplified framework 
failed to capture the complexity of diverse T cell memory response (Jameson and Masopust, 
2009). The majority of T cells in non-lymphoid organs do not express CCR7 or CD62L 
(Spetz et al., 1996; Campbell et al., 2001; Clark et al., 2006), implicating a TEM phenotype. 
However, it has been shown that memory T cells egress from nonlymphoid tissue in a CCR7 
dependent manner (Bromley et al., 2005; Debes et al., 2005; Bromley et al., 2013). This 
implies that at least part of the memory T cell population patrolling the peripheral tissues 
would express CCR7; therefore, violating of the TCM / TEM model. In parabiotic mice model, 
non-circulating T cell population was found in many non-lymphoid tissues (e.g. intestine, 
female reproductive tract), whereas T cell population from lung and liver equilibrated with 
the circulating population (Klonowski et al., 2004; Masopust et al., 2010; Steinert et al., 
2015). This illustrates complexity of the diversity of the migratory pattern of the TEM 
population. One example of such non-recirculating resident T cells population is the 
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intraepithelial T lymphocytes (IELs) in the intestine that could exert antigen-specific 
cytolysis upon reactivation (Masopust, 2001).  
The studies on skin and nerve-tropic herpes simplex virus (HSV) infection and recall 
response to the virus in experimental murine model illustrated the pivotal role of resident T 
cell population in tissue immunology. HSV can infect the skin of both human and mice. In 
humans, the virus resides within sensory ganglia in a latent state; upon reactivation, skin 
lesions relapse at previously affected sites (Koelle and Corey, 2008). In contrast, 
“spontaneous” reactivation does not occur in vivo at the periphery in murine HSV infection 
despite the presence of latent virus in sensory ganglia (Feldman et al., 2002). It was found 
that, in mouse, HSV-specific memory CD8+ T cells are retained in the sensory ganglia during 
latency (Khanna et al., 2003), and can expand locally upon antigenic activation (Wakim et 
al., 2008). Gebhardt and colleagues illustrated that after primary HSV cutaneous infection, 
HSV-specific CD8 T cells preferentially persist in the previously infected skin epithelia and 
provide local recall response against HSV reinfection in the skin (Gebhardt et al., 2009). This 
resident population was then termed the Tissue-resident memory T (TRM) cells. The 
protective role of local adaptive immune defence mediated by TRM cells was further 
confirmed in murine viral infection models of the brain (Wakim et al., 2010), gut mucosa 
(Masopust et al., 2010; Zhang and Bevan, 2013), lung (Wakim et al., 2013), and female 
productive tract (Schenkel et al., 2013; Schenkel et al., 2014) as well as skin vaccinia virus 
infection (Jiang et al., 2012). Apart from viral infection, microbiota and non-infectious 
inflammation could induce the formation of TRM cells (Mackay et al., 2012; Naik et al., 
2012).  
A definitive characteristic of TRM cells is their ability to reside in non-lymphoid tissue and, 
thus, do not recirculate (Gebhardt et al., 2011; Clark et al., 2012; Jiang et al., 2012; Mueller 
et al., 2013; Steinert et al., 2015). Similar transcriptome profiles of TRM cells from different 
tissues, gut, lung, brain and skin showed gene expression signature that favours tissue 
retention (Wakim et al., 2012; Mackay et al., 2013). This ability to persist in tissue is thought 
to be mediated by the expression of TRM cell markers, CD103, CD69 and CD49a (Gebhardt 
et al., 2009; Wakim et al., 2010; Zhang and Bevan, 2013). CD103, also known as integrin 
αE, is part of the heterodimer integrin αEβ7 that binds to E-cadherin (Cepek et al., 1994), 
which forms adherent junctions widely expressed in epithelial cells (Hartsock and Nelson, 
2008) and some dendritic cells (Tang et al., 1993). It was postulated that the CD103 
expression is required for TRM during epithelial adhesion and retention (Pauls et al., 2001). 
CD69, on the other hand, is infamously known as the “early activation marker” for 
lymphocytes; however, CD69 can also suppress sphingosine 1-phosophate receptor-1 (S1P1) 
expression (Bankovich et al., 2010) and allow TRM to stay in non-lymphoid tissue (Mackay et 
al., 2015a). Indeed, down-regulation of S1P1 is required for resident memory CD8+ T cell 
formation (Skon et al., 2013). CD49a, also known as Very Late Antigen-1 (VLA-1), is the α1 
subunit of the α1β1 integrin (Hemler, 1990; Hynes, 2002) that could adhere to collagen IV, a 
component of the basement membrane between epidermis and dermis. CD49a has been 
suggested to mediate epidermal-tropic migration and is critical in development of psoriasis in 
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a spontaneous xenotransplant model (Conrad et al., 2007). Additionally, CD49a marks lung-
resident T cells, and was proposed to mediate their tissue retention after active viral infection 
(Ray et al., 2004; Chapman and Topham, 2010; Piet et al., 2011; Purwar et al., 2011). 
Importantly, the expression of these TRM markers do not capture all the non-recirculating T 
cells in the tissue (Steinert et al., 2015). Nonetheless, these markers provide the tools to 
identify TRM cells in peripheral tissue.  
The development of TRM cell depends on TGF-β and IL-15. TGF β up-regulates TRM 
markers, CD103, CD69 and CD49 (Mackay et al., 2013; Zhang and Bevan, 2013), whereas 
IL-15 provides survival signals (Adachi et al., 2015; Mackay et al., 2015b). Most functional 
studies on TRM cell have focused on CD8 TRM, but both CD4 and CD8 TRM have been 
identified and characterized in the lung, intestine, female genital tracts and skin (Gebhardt et 
al., 2011; Iijima and Iwasaki, 2014; Thome et al., 2014; Turner and Farber, 2014; Glennie et 
al., 2015; Watanabe et al., 2015). Whether CD4 T cells are re-circulating or lodging in these 
non-lymphoid tissue is, however, less clear. Even in the absence of cognate antigens, CD8 
TRM cells constantly crawl within the epithelial allowing rapid detection of antigen (Ariotti et 
al., 2012; Zaid et al., 2014). Among the proposed effector mechanisms, IFN-γ induced 
inflammation has been suggested as the major protective mechanism of the TRM-mediated 
local recall response (Schenkel et al., 2013; Ariotti et al., 2014; Schenkel et al., 2014; 
Glennie et al., 2015) (Figure 2.4). 
 
Figure 2.4. Protective Effector Mechanism of CD8 TRM cells. Even without the presence of cognate antigens, 
TRM constantly crawl within the epithelium (Ariotti et al., 2012; Zaid et al., 2014). Upon antigen stimulation, 
their protective function through multiple mechanisms: (1) IFN- γ induced inflammation; (2) chemokine 
production; (3) bystander activation of cytotoxic lymphocytes and; (4) induction of DC maturation (Schenkel et 





3 THE SKIN 
The skin serves as the interface between the body and the surrounding environment. It forms 
a critical barrier against physical and chemical insults, as well as foreign entities such as 
pathogens and commensal microbes. Structurally, human skin is composed of three basic 
layers, the epidermis, dermis, and subcutis (Figure. 3.1). The subcutis lies beneath dermis, 
consisting of connective and adipose tissues. The skin also contains various skin appendages, 
such as hair, sebaceous glands and sweat glands that exert further physiological functions. 
 
Figure 3.1. Structure of the human skin Left. Overall structure of human skin with epidermis and dermis as 
well as hypodermis. (a. hair shaft, b. arrector pili muscle, c. hair, d. sebaceous gland, e hair root and follicle, f, 
adipose tissue, g, sensory nerve fibre, h. blood vessels, i. pacinian corpuscle, j. eccrine sweat gland) Right. 
Architecture of epidermal layers.  (Images downloaded for free and modified from OpenStax College, Anatomy 
& Physiology. OpenStax CNX. http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22. Creative 
Commons Attribution 4.0 International License.) 
The epidermis is composed of multiple layers of tightly packed keratinocytes that form the 
basis for the physical barrier. Under homeostatic conditions, keratinocytes in the basal layer 
proliferate, migrate upward, differentiate and, ultimately, form the cornified layer, stratum 
corneum, before being gradually exfoliated (Figure 3.1). Melanocytes, which can produce 
skin pigment, also situated in the basal layer of the epidermis. A collagen-rich basement 
membrane anchors the two distinct layers and forms the epidermal-dermal junction. The 
dermis is connective tissue made of collagen and elastic fibres; thereby, supporting the 
epidermis and allowing elasticity of the skin. Fibroblasts and nerve fibres lie within the 
dermis. Blood vessels and lymphatics also drain to the dermis, supplying nutrients and 
circulation to the skin. 
3.1 The Cutaneous Immune System 
The skin consists of both innate and adaptive immune cell types. In the 1980s, based on 
evidence of the presence of immunocompetent cells in skin, Streilein proposed the concept of 
skin-associated lymphoid tissue (SALT), which could protect against persistent infection or 
neoplasms, (Streilein, 1983). However, in contrast to its mucosal counterpart, i.e. mucosa-
associated lymphoid tissue (MALT), the skin at steady state lacks B cells (Bos et al., 1987) 
and well-defined lymphoid tissue structure (Pitzalis et al., 2014). Aside from keratinocytes, 
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which provide the first line of innate defence, many immune cell types are present in the skin 
during healthy or inflammatory states. Among the immune cells, dendritic cells and T cells 
play a critical role in adaptive immune response; whereas mast cells, neutrophils, innate 
lymphoid cells (ILCs), macrophages, fibroblasts and endothelial cells secrete inflammatory 
mediators and take part in inflammation. Recently, Kabashima and colleagues proposed the 
formation of inducible SALT (iSALT) during inflammation, which involves formation of T 
cell – dendritic cell clusters and requires initial innate signals from macrophages and 
keratinocytes (Natsuaki et al., 2014), illustrating the dynamic interaction of immune and 
stromal cells in skin inflammation. 
3.1.1 Keratinocytes 
The keratinocyte is the most abundant cell type in the human epidermis and forms a stratified 
epithelium. Such cellular architecture is the basis of the physical barrier. Indeed, an intact 
physical barrier limits microbial growth and pathogen invasion (Goodarzi et al., 2007). When 
the physical barrier is compromised, immune mechanisms are required to be in place for 
pathogen detection and elimination. The innate immune function of keratinocytes, therefore, 
serves as the first line of defense against intruders. 
The innate immune system rapidly acts against a broad spectrum of pathogens. Compared 
with adaptive immune cells, innate cell types have a limited set of receptors recognizing 
common structural patterns of pathogens that are called pathogen-associated molecular 
patterns (PAMPs) (Janeway, 1992). Pattern Recognition Receptors (PRRs) sense the 
presence of pathogens. Toll-like Receptors (TLRs) are amongst the most studied PPRs. There 
are ten human TLRs, which are expressed either on the cell surface or the endosomal 
compartments, sensing different evolutionarily conserved PAMPs (Kumar et al., 2011). 
Keratinocytes express a specific set of TLRs (TLR 1-5 and 9) (Miller and Modlin, 2007; 
Nestle et al., 2009a). Upon TLR-activation, keratinocytes produce various cytokines and 
chemokines. Among them, the IL-8, TNF, and type I interferons, for example, further 
amplify the inflammatory response (Miller and Modlin, 2007; Kawai and Akira, 2010). These 
initial proinflammatory mediators derived from keratinocyte would regulate further 
inflammatory responses, including recruitment and activation of other cell types, like 
neutrophils, and dendritic cells. 
Antimicrobial peptides (AMPs), like defensin, cathelicidin (LL37) and psoriasin (S100A7) 
are also produced by keratinocytes (Gallo and Hooper, 2012). The bactericidal effects of 
AMPs are usually mediated through targeting bacterial cytoplasmic membrane (Gallo and 
Hooper, 2012). In addition to their antimicrobial activities, AMPs can be induced during 
inflammation and wounding (Frohm et al., 1997) . And it is increasingly recognized that 
some AMPs have non-bactericidal functions in inflammatory processes; for instance, AMPs 
binding with nucleic acids could also activate cells through TLRs, showing multiple 




3.1.2 Dendritic Cells in the Skin 
Dendritic cells (DCs) are professional antigen presenting cells that link the innate and 
adaptive immunity. As professional antigen presenting cells, they express MHC class-II and 
are capable of activating CD4 T helper cells. Certain subsets of DCs may also present 
extracellular antigens on MHC class I molecules to CD8 T cells through a process called 
cross-presentation (Segura and Amigorena, 2014). Through antigen presentation, co-
stimulation/co-inhibition and cytokine production, DCs serve crucial stimulatory and 
regulating functions for T cell immunity (Steinman, 2012).  
At steady state, the skin is the home to different subsets of tissue dendritic cells distinct by 
their anatomical distribution. The Langerhans cell (LC) is the major DCs type in the 
epidermis, whereas a more diverse group of dermal DCs reside in the dermis, including 
CD1c+ DCs and CD141+DCs during steady state, as well as plasmacytoid DCs, TIP (TNF- 
and iNOS-producing) DCs and SLAN DCs during inflammation (Lowes et al., 2005; Zaba et 
al., 2008; Brunner et al., 2013; McGovern et al., 2014). LCs were once considered as the 
classical model of tissue resident DCs. The “Langerhans cell paradigm” postulated that LCs 
capture and process the antigens from the pathogens in the skin, and simultaneously become 
activated by the inflammatory milieu (Romani et al., 2010). Subsequently, LCs migrate to the 
lymph node to present foreign antigens to T cells; thereby, initiating the T cell activation. 
However, this paradigm has been questioned; LCs alone could not initiate cytotoxic T cells 
response to viral infection in epidermis (Allan et al., 2003). It was later found that dermal 
DCs, but not LCs, were able to carry antigen to draining lymph node (Allan et al., 2006) and 
induce T cell proliferation (Fukunaga et al., 2008) or CD8-mediated response (Bedoui et al., 
2009). Some experimental contact hypersensitivity models, however, suggested that LCs and 
dermal DCs might be redundant or compensatory in T cell priming (Noordegraaf et al., 2010; 
Clausen and Stoitzner, 2015). In light of the polarization of T helper cell subsets, recent 
studies showed that Langerhans cells are in favour of inducing Th17 (Kashem et al., 2015) or 
Th22 (Fujita et al., 2009) while dermal DCs promote Th1 differentiation (Igyártó et al., 
2011). LCs may also activate skin resident Tregs (Seneschal et al., 2012). Discrepancy in the 
literature about the function of LCs and dermal DCs illustrates the multifunctional nature of 
these skin DC subsets and the precise function might be highly dependent on the context of 
the investigation. Importantly, epidermal TRM cells in skin interact with Langerhans cells and, 
thus, LCs may be important function in regulating functions of TRM cells (Zaid et al., 2014).  
3.1.3 T Cells in the Skin 
Circulating T cells homing to skin predominately express cutaneous lymphocyte-associated 
antigen (CLA), which is an inducible modification of P-selectin glycoprotein ligand-1 
(PSGL-1) (Fuhlbrigge et al., 1997). However, the majority of CLA expressing T cells reside 
in the skin, and it has been estimated that there are two times more T cells in the skin than 
that in the circulation (Clark et al., 2006). In steady state, epidermal T cells are often situated 
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in the basal layer along the rete ridges; whereas dermal T cells are positioned just beneath the 
epidermal-dermal junction or surrounding blood vessels in both papillary and reticular dermis 
(Bos et al., 1987; Foster et al., 1990). Most T cells in human skin are αβ T cells, and both 
CD4 and CD8 T cells reside in epidermis and dermis (Bos et al., 1987; Foster et al., 1990; 
Spetz et al., 1996). Interestingly, epidermis from sole of the feet has significantly higher T 
cell density as compared to buttock, limbs and 
thorax, indicating regional difference (Foster et 
al., 1990). Early functional analysis showed that 
cutaneous T cells could activate autologous 
keratinocytes to express ICAM-1 (Sugerman and 
Bigby, 2000). HSV specific CD8 T cells persist 
in human genital skin and accumulate close to 
nerve ending during subclinical HSV activation 
(Zhu et al., 2007; Zhu et al., 2013). During 
clinical quiescence CD8 T cells at epidermal-
dermal junction retain effector-like gene 
expression profile (Peng et al., 2012). Apart from 
HSV, skin resident T cells specific to other 
viruses have also been identified, e.g. Varicella 
Zoster Virus Skin (VZV) (Vukmanovic-Stejic et 
al., 2015) and human papillomavirus (HPV) (Viac et al., 1992), implicating a general role in 
immune surveillance.  
Most T cells in epidermis and dermis express CD45RO and lack CD62L, indicating a TEM 
cell phenotype (Spetz et al., 1996; Clark et al., 2006). CD103 is expressed in a significant 
population of epidermal CD8 T cells (Spetz et al., 1996) and has been proposed to mediate 
adhesion to epidermis (Pauls et al., 2001). CD45RO+ Foxp3+ Tregs often reside in hair 
follicles (Sanchez Rodriguez et al., 2014). Apart from CLA, skin homing or resident T cells 
may express a set of chemokine receptors including CCR4, CCR6, CCR8, and CCR10. 
(Homey et al., 2002; Hudak et al., 2002; Clark et al., 2006; McCully et al., 2012). Since TRM 
cells were first identified in murine skin model, CD69+ CD103+ TRM cells have also been 
identified in human skin and display a higher potential for producing IFNγ, TNF and IL-22 as 
compared to the CD103- population (Watanabe et al., 2015). The expression of CD49a in 
human TRM cells from healthy skin is less studied. However, early histology studies and long-
term explant culture did show the presence of CD49a+ in healthy skin (Foster et al., 1990; 
Purwar et al., 2011). In murine models, TRM cells can be defined by the tissue retention and 
non-recirculating properties. In human, such functional characterization is difficult, but 
application of alemtuzumab (anti-CD52) to cutaneous lymphoma patients and skin transplant 
onto immunodeficient mice demonstrated retention of TRM cells or skin resident TEM cells in 
human skin (Clark et al., 2012; Watanabe et al., 2015). A re-circulating T cell population 
lacking CD103 and CD69 expression that expresses CCR7 has also been identified; thus, 
Figure 3.2. T cell subsets in the human skin  
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human skin is protected by both resident and re-circulating T cell populations (Watanabe et 
al., 2015).  
Animals raised in a germ-free environment had few skin resident T cells (Clark, 2015). In 
line with that, few resident T cells were found in prenatal and newborn skin (Schuster et al., 
2012; Watanabe et al., 2015). The lack of αβ TRM cells prior to infection indicates that TRM 
cells are likely to develop with time when the skin tissue is challenged immunologically. In 
mice, formation of TRM cells requires either viral challenge or epithelial inflammation 
(Mackay et al., 2012). In addition, over 1010 bacterial cells cover the skin of a healthy human 
body (Grice et al., 2008) and the colonization of specific commensal bacteria leads to the 
development of resident T cell subset with specialized immune response (Naik et al., 2012; 
Naik et al., 2015). A recent study suggested Tregs rapidly migrate into the neonatal skin and 
form the peripheral tolerance to microbial commensals (Scharschmidt et al., 2015). 
Therefore, the skin microbiota play a crucial part in the development of the cutaneous 
immune system but the microbial burden also imposes immunologic pressure on the skin. 
Apart from providing adaptive immune surveillance and immune-tolerance to the skin, T 
cells drive pathology in many types of skin diseases. In lesions of common chronic 
inflammatory skin disorders such as atopic dermatitis and psoriasis, T cells with distinct 
cytokine expression profiles were observed. Atopic dermatitis lesions contain distinct Th2 
and Th22 subsets while chronic lesions also contain Th1 cells; whereas psoriasis lesions 
contain Th/Tc1 and Th/Tc17 subsets (Lowes et al., 2008; Nograles et al., 2009; Eyerich et 
al., 2011; Gittler et al., 2012; Hijnen et al., 2013). The distinct cytokine patterns of the two 
diseases contribute to the different histological and clinical outcome (Guttman-Yassky et al., 
2011). Allergic contact dermatitis is characterised by the delayed type hypersensitive reaction 
mediated by Th1 and CD8 T cells (Fyhrquist et al., 2014; Gulati et al., 2014).  Cytotoxic 
function of T cells has also been implicated particularly in diseases such as vitiligo and 
alopecia (Mandelcorn-Monson et al., 2003; Xing et al., 2014). In fixed drug eruption, 
intraepidermal CD8 T cells respond rapidly to clinical challenge of causative drugs with IFN-
γ, perforin and granzyme B expression (Teraki and Shiohara, 2003; Mizukawa et al., 2008). 
Also, in acute wounds, T cells are able to produce insulin-like growth factor 1, potentially 
participating in wound healing process (Toulon et al., 2009). These examples highlight the 
contribution of T cells in a broad spectrum of diseases and inflammation. 
3.1.4 Cytokines 
Cytokines are a group of relatively small proteins that mediate communication between cells. 
Cytokine signals transduce through specific cytokine receptors expressed on the cell surface. 
They usually have a short range of effects through autocrine, paracrine or juxtacrine 
stimulation. Every cell type in the skin is able to produce some cytokines (Nickoloff et al., 
2007). Keratinocytes, in particular, can produce many cytokines, among them, IL-1, IL-6, IL-
10, IL-18 and TNF (Nestle et al., 2009a). These cytokines serve as potent amplifiers of local 
inflammatory responses and act on multiple cell types. The IL-2 family cytokines are 
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particularly important in survival or activation of T cells.  In skin, hair follicle-derived IL-7 
and IL-15, members of the IL-2 family cytokines, mediate homeostasis of memory T cells in 
the murine skin (Adachi et al., 2015). Aside from being a potent cytokine producer, 
keratinocytes can respond to various cytokines produced by other cell types; in particular, 
IFN-γ, IL-17 and IL-22 from T cells; thereby, forming a T cell - keratinocyte cytokine 
network in skin inflammation. 
IL-15 is an important cytokine for homeostasis of CD8 T cells and Natural Killer (NK) cells. 
Its receptor (IL-15R) shares the same β subunit (CD122) and the common γ chain (CD132) 
with the IL-2 receptor (Liao et al., 2011). Its downstream signaling, which involves Janus 
kinase (Jak) 1 and 3, and STAT5, promotes survival signals for T cells (Liao et al., 2011).  
Homeostatic proliferation of memory CD8 T cell is depended on IL-15 (Goldrath, 2002; 
Judge et al., 2002). In contrast to IL-2, which usually acts in either autocrine or paracrine 
manner, IL-15 can, additionally, be trans-presented by IL-15Rα to activate T cells (Dubois et 
al., 2002). Apart from its role in homeostasis of CD8 T cells, IL-15 could also promote 
optimal memory T cell-mediated response (Richer et al., 2015). In a murine HSV skin 
infection model, IL-15 is critical in the formation and maintenance of TRM cells in (Mackay et 
al., 2013; Mackay et al., 2015b). In addition, IL-15 stimulation may promote proliferation of 
regulatory T cells in human skin (Clark and Kupper, 2007).   
IFN-γ is the characteristic cytokine produced by Th1, NK cells and CD8 T cells. IFN-γ 
promotes expression of MHC molecules and boosts cellular antiviral machinery (Samuel, 
2001). Of interest, unlike other proinflammatory cytokines, IFN-γ inhibits proliferation of 
keratinocytes (Hattori et al., 2002).  It can induce expression of more than 200 genes related 
to inflammation in epithelial cell (Sanda et al., 2006) and production of cytokines (e.g. IL-1, 
IL-6 IL-15) by keratinocytes (Teunissen et al., 1998). In addition, IFN-γ induces production 
of chemokines (CCL5, CXCL9, CXCL10, and CXCL11) and up-regulation of adhesion 
molecules (Rashighi et al., 2014). TRM cells generated from viral infection particularly 
employ IFN-γ to induce localized inflammation and antiviral responses (Chapman et al., 
2005; Schenkel et al., 2013; Ariotti et al., 2014; Schenkel et al., 2014).  
IL-17 is the signature cytokine produced by Th17 and Tc17 cells. Neutrophils, mast cells, γδ 
T cells and innate lymphoid cells can also produce IL-17 in skin during inflammatory 
conditions such as psoriasis (Res et al., 2010; Laggner et al., 2011; Lin et al., 2011; 
Teunissen et al., 2014a; Villanova et al., 2014). Essentially, IL-17 is not one single cytokine 
but a family of cytokines, namely, IL-17A-F. Among them, IL-17A and IL-17F are the most 
studied. They could either form homodimer or heterodimer, and signal through IL-17 
receptor complex composed of IL-17RA and IL-17RC (Gaffen, 2009). IL-17 is a potent 
inducer of proinflammatory cytokines and chemokines, especially CXCL1, IL-8, and CCL20, 
as well as antimicrobial peptides (Liang et al., 2006). Skin resident T cell subsets respond to 
commensals with IL-17 production (Naik et al., 2012). Genetic deficiency within the IL-17 
and Th17- related pathway is associated with chronic mucocutaneous candidiasis (Cooper et 
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al., 2015; Ling et al., 2015). In addition, IL-17 is the critical pathogenic cytokine in psoriasis 
and serves as an effective target for therapy (see Psoriasis section).  
IL-22 is a member of the IL-10 cytokine family. The IL-22 receptor is expressed on epithelial 
cells, but not on immune cells (Wolk et al., 2004). IL-22 is a key cytokine during epithelial 
homeostasis and inflammation. Initially, it was considered that IL-22 was expressed by Th17 
cells, but it was later found that IL-22 could also be expressed by Th1, or, a subset which did 
not produce IFN-γ or IL-17, i.e. Th22 (Duhen et al., 2009; Eyerich et al., 2009). Recently, 
mast cells and innate lymphoid cells have been suggested to be efficient IL-22 producers 
(Cupedo et al., 2008; BPharm et al., 2015)). The gene expression of IL22 is regulated by Aryl 
Hydrocarbon receptor (AHR), which can be activated by xenobiotic chemicals (Veldhoen et 
al., 2008; Ramirez et al., 2010). On keratinocytes, IL-22 induces strong antimicrobial 
response and promotes hyper-proliferation of keratinocytes (Wolk et al., 2004; Wolk et al., 
2006). It can also potentiate inflammatory response mediated by TNF (Eyerich et al., 2009). 
IL-22 has been proposed as a pathogenic cytokine in psoriasis and has also been implicated in 
atopic dermatitis (Nograles et al., 2009; Eyerich et al., 2011). However, IL-22 has a 
protective role in inflammatory bowel disease and gut pathology, indicating its tissue-specific 
roles (Ouyang, 2010).  
3.2 Human vs. Mouse  
Much of our understanding about immunology and skin inflammation is derived from 
experimental murine models. While a large proportion of the knowledge is transferable 
between species, it is important to bear in mind the differences between human and mouse. 
Mouse skin is covered by fur and has a higher density of hair follicles than human skin. The 
epidermis of mice contain only 2-3 layers of keratinocytes and is only one-quarter of the 
thickness of human epidermis; therefore, mice skin also has a higher turnover rate 
(Gudjonsson et al., 2007). Although LCs are present in both human and mice epidermis, 
dermal DCs with a different set of phenotypic markers were observed in human and mouse 
skin (Heath and Carbone, 2009; Haniffa et al., 2015). Attempts have been made to correlate 
the functionality of different subsets of DCs across species (Ginhoux et al., 2012; McGovern 
et al., 2014). Sharply contrasting with human skin is the constitution of dendritic epidermal γδ T cells (DETCs) in mouse epidermis. DETCs bear the invariant Vγ1 Vδ6 TCR and	   form 
immune synapse-like structures with squamous keratinocyte tight junctions in the steady 
state, indicating that DECTs may recognize a self-ligand expressed by keratinocyte 
(Chodaczek et al., 2012). Such interactions are crucial in the development of epidermis as 
mice without DETCs has aberrant keratinocyte homeostasis and impaired wound healing 
(Jameson et al., 2002). Previous studies also showed that DETCs might mediate immune 
surveillance through signaling by NKG2D, which senses stress-induced ligands (Girardi et 
al., 2001; Hayday and Tigelaar, 2003; Strid et al., 2011). In the murine HSV model, DETCs 
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and αβ TRM cells shared epidermal niches and the formation of TRM cell is associated with the 
decrease density of DETCs in the infected region (Zaid et al., 2014). Some of the 
immunosurveillance strategies of DETCs may be employed by TRM cells in human, but the 




4 SKIN DISEASES 
The human skin can be affected by a broad spectrum of diseases, ranging from infections to 
malignancies and immune-mediated diseases. Forming the external barrier, the skin is 
subjected to immunologic challenges of different pathogens. Exposure to chemical 
substances, UV radiation, and certain pathogens, such as HPV, increase the risk of 
developing skin malignancy (Akgül et al., 2006) and lymphomas derived from different T 
cell subsets also affect the skin (Campbell et al., 2010).  Several groups of immune-mediated 
diseases target the skin: autoimmune diseases like pemphigus; common inflammatory 
diseases such as psoriasis; and allergic diseases exemplified by allergic dermatitis. In some 
cases, this classification fails to recognize the complexity of the pathogenic mechanism as 
evidenced by psoriasis and vitiligo, in which both autoimmune and inflammatory 
mechanisms have been proposed. Nonetheless, the etiology of these diseases, so-called 
multifactorial diseases, involves predisposition of multiple genetic factors interacting with 
environmental triggers that lead to dysregulation of the immune system. 
4.1 Psoriasis 
Psoriasis is a common chronic inflammatory skin disease affecting 2-3 % of the world 
population (Lowes et al., 2007; Nestle et al., 2009b). Psoriasis can occur early on in 
childhood, but its onset usually starts in late adolescence and affects males and females 
equally (Farber and Nall, 1974; Mallbris et al., 2005). The severity and area of affected skin 
vary among patients and can be assessed by Psoriasis Area and Severity Index (PASI), 
Physician Global Assessment (PGA) or Body Surface Area (BSA). There is a huge diversity 
in the phenotypes of psoriasis, ranging from acute widespread small lesions associated with 
throat infection (guttate psoriasis) to pustular lesions affecting the palms and soles (palmo-
plantar psoriasis) or the whole body (generalized pustular psoriasis). Plaque psoriasis is the 
most common type of psoriasis accounting for 90% of all 
psoriasis cases (Boehncke and Schön, 2015). Plaque 
psoriasis is clinically defined by the formation of 
demarcated erythematous plaques with silvery scales 
(Nestle et al., 2009b) (Figure 4.1). Although primarily 
affecting the skin, psoriasis could affect patients 
systemically with psoriatic arthritis, nail dystrophy, 
metabolic dysregulation, cardiovascular diseases and other 
inflammatory conditions as co-morbidities (Nestle et al., 
2009b; Davidovici et al., 2010). Nowadays, effective 
treatments are available, but psoriasis cannot be cured 
and may relapse preferentially at sites of previous 
inflammation (Clark, 2011). 
Figure 4.1 Plaque Psoriasis 
Courtesy of Dr. Liv Eidsmo 
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4.1.1 Genetics 
The genetic impact of psoriasis is evident in family and twin studies where concordance rate 
of monozygotic twins and dizygotic twins has been estimated as 35–72% and 12–23% 
respectively (Farber et al., 1974; Bowcock, 2005). Early tissue typing studies suggested that a 
high proportion of psoriasis patients carried a specific HLA-C type (McMichael et al., 1978). 
Indeed, through classical linkage and sequencing analysis, the HLAC region has been 
identified as the most significantly associated locus with psoriasis susceptibility (Asahina et 
al., 1991; Trembath et al., 1997; Nair et al., 2000), with HLA-Cw6 (HLA-C*0602) being 
identified as the susceptible risk allele (Nair et al., 2006). Additionally, HLA-C*0602 has 
found to be particularly prevalent in patients with early onset of diseases or with the guttate 
phenotype (Enerbäck et al., 1997; Gudjonsson et al., 2002; Lysell et al., 2013). Human 
Leukocyte Antigen (HLA)-C is one of the classical MHC class I molecule in human 
alongside with HLA-A and HLA-B. HLA molecules are highly polymorphic with some of 
the most variable genetic traits in the human population. As a classical MHC class I 
molecule, HLA-C could present peptide antigens to CD8 T cells and trigger potent cytotoxic 
and cytokine responses (Blais et al., 2011). With the technological advance of the genome 
wide association study (GWAS) on large cohorts of patients, another gene within antigen 
presentation pathway, ERAP1, has been identified as a psoriasis susceptible gene 
(Consortium et al., 2010; Sun et al., 2010). ERAP1 encodes for the endoplasmic reticulum 
aminopeptidase 1, which cleaves peptides for MHC-class I presentation. Interestingly, in 
Swedish patients, the genetic association of ERAP1 is only confined to patients with disease 
onset between 10-20 years of age (Lysell et al., 2013). 
Apart from ERAP1, many new loci have been identified associated with psoriasis by GWAS 
within to the IL-23/Th17 pathways (IL12B, IL23A, IL23R), innate immunity, TNF receptor 
signaling and downstream NFκB pathway (e.g. TNIP1, TNFAIP3, CARD14) (Liu et al., 
2008; Nair et al., 2009; Jordan et al., 2012; Tsoi et al., 2012; Harden et al., 2015b). 
Functionally, Th17 cells from individuals with the protective allele of IL23R show IL-23 
unresponsiveness, indicating functional consequence of genetic association (Di Meglio et al., 
2013); while variants in CARD14 could increase NFκB signaling and lead to increased 
production of proinflammatory cytokines or chemokines production in keratinocytes, 
providing functional links to these genetic associations (Jordan et al., 2012). Despite being 
primarily a skin condition, surprisingly few genes closely related to skin function are 
associated with psoriasis. LCE genes, encoding for the late cornified envelope (LCE) proteins 
important for epidermal differentiation, remain the few examples of susceptible genes related 
to skin function (de Cid et al., 2009; Zhang et al., 2009).   
The identification of psoriasis associated genetic variants has increased our understanding of 
the pathogenesis of psoriasis in which both innate and adaptive immunity are involved. Some 
genetic variations are more enriched in certain subgroups of patients, highlighting the delicate 




The epidermal pathology of psoriasis is characterized 
by acanthosis, parakeratosis and elongation of rete 
ridges (Figure 4.2), which are the results of 
hyperproliferation of keratinocytes and dysregulation 
of keratinocyte differentiation. Dysfunctional 
keratinocytes were once thought to be the sole cause 
for psoriasis, but it is now appreciated that the massive 
infiltration of inflammatory cells, including T cells, 
dendritic cells, neutrophils, mast cells (Lin et al., 
2011), innate lymphoid cells (Teunissen et al., 2014a; 
Villanova et al., 2014) among others, provide proinflammatory stimuli to the keratinocytes. T 
cells producing high level of proinflammatory cytokines, in particular, play a vital role to 
activate keratinocytes in psoriasis (Boyman et al., 2007; Nestle et al., 2009a). Over the past 
two decades, much effort has been put into understanding different aspects of the 
pathogenesis of psoriasis (Lowes et al., 2007; Nestle et al., 2009b; Boehncke and Schön, 
2015) (Figure. 4.3). 
 
Figure 4.3.  Proposed Immunopathogenesis of Psoriasis. Reproduced with permission from (Nestle et al., 
2009b). Copyright Massachusetts Medical Scociety. 
Figure 4.2 Histology of Plaque Psoriasis.  
Courtesy of Dr. Mari-Anne Hedblad 
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4.1.2.1 Innate Immune Cell Initiates Psoriasis Plaques Formation 
Although the exact triggers for psoriasis are yet to be identified, the initiation of psoriasis 
inflammation may stem from cellular stress imposed on keratinocytes. These potential 
triggers include infections, drugs, injuries and psychological stress (Nestle et al., 2009b). 
Keratinocytes produce proinflammatory mediators including cytokines, chemokines, and 
antimicrobial peptides in response to cellular stress. The cathelicidin antimicrobial peptide, 
LL37, in particular, could form complexes with nucleic acids and activate different DCs 
subsets through TLR's signaling. For instance, LL-37-RNA complexes activate mDC through 
TLR7/8 (Ganguly et al., 2009), whereas LL-37-DNA complexes activate pDC through TLR9 
which promotes IFNα production (Lande et al., 2007). In a xenotransplant mouse model of 
psoriasis, IFNα production from plasmacytoid dendritic cells (pDC) was crucial for the 
initiation of psoriasis inflammation (Nestle et al., 2005). The role of IFNα in precipitating 
psoriasis has also been demonstrated clinically when patients receive IFNα therapy (Funk et 
al., 1991). 
4.1.2.2 Chronic Psoriasis Results from Cytokine Overexpression 
Given the early inflammatory milieu created by both keratinocytes, pDCs, and other local cell 
types, it has been proposed that activated dermal dendritic cells would migrate to the draining 
lymph nodes, and subsequently, activate and polarize T cells to Th/Tc1 or Th/Tc17 
responses. Activated T cells released from skin draining lymph nodes preferentially enter the 
skin at inflamed sites due to the increase in chemokines such as CXCL9, CXL10 and CCL20 
and secrete pathogenic cytokines IFNγ, TNF, IL-17, and IL-22 (Fierlbeck et al., 1990; 
Schlaak et al., 1994; Lowes et al., 2008; Nograles et al., 2008; Ortega et al., 2009; Res et al., 
2010). The proinflammatory environment also prevents the Tregs mediated 
immunosuppression (Goodman et al., 2009) and Tregs shifting to become IL-17 producing 
cells has been reported (Bovenschen et al., 2011). Activated neutrophils, mast cells and 
innate lymphoid cells accumulated in psoriasis lesions are additional sources of IL-17 and IL-
22 cytokines; therefore, a number of immune-cells contribute the pathogenesis to the disease 
(Fuentes-Duculan et al., 2010; Lin et al., 2011; Teunissen et al., 2014a; Villanova et al., 
2014; BPharm et al., 2015). Together, these pathogenic cytokines activate keratinocytes to 
hyper-proliferate and produce more antimicrobial peptides, proinflammatory cytokines, and 
chemokines; thereby, expanding the recruitment of immune cells into the lesion and creating 
a positive feedback vicious cycle (Figure. 4.3). 
4.1.2.3 Pathogenic Role of T Cells in Psoriasis 
The pathogenic involvement of T cells in psoriasis has been shown in different settings long 
before the discovery of IL-23/Th17 as the key pathogenic pathway. Early clinical reports 
showed that bone marrow transplantation from a donor with psoriasis could lead to onset of 
the disease in recipient with no history of psoriasis (Gardembas-Pain et al., 1990), indicating 
that psoriasis can be transferred by blood-borne cells. Infusion of monoclonal antibodies 
depleting CD4+ T cells has been shown to reduce severity of psoriasis (Prinz et al., 1991; 
Morel et al., 1992). In animal models of psoriasis, where human skin is transplanted onto the 
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severe combined immunodeficiency (SCID) mice, maintenance of skin pathology within 
grafted lesional psoriasis skin is T cell-dependent (Gilhar et al., 1997). Besides, intradermal 
injection of blood derived activated CD4+ cells to uninvolved skin from psoriasis patients 
could induce active psoriasis (Nickoloff and Wrone-Smith, 1999). Transplanting uninvolved 
skin from psoriasis patients onto severely immunocompromised (AGR) mice spontaneously 
induced psoriasis without blood derived cells; blocking of T cells in this model showed that 
the spontaneously psoriasis development was resident T cell- dependent (Boyman et al., 
2004). Using the same model, the group further demonstrated that the infiltration of CD49a+ 
epidermal T cells, but not dermal T cells, is associated with the development of psoriatic 
inflammation (Conrad et al., 2007). Clinically, Alefacept (a soluble LFA-3Ig) showed 
therapeutic efficacy associated with depletion of T cells, which is the major cell type 
expressing CD2 in the lesion (Chamian et al., 2007). Overall, overwhelming evidences 
support the involvement of T cells and their cytokine production in psoriasis pathogenesis. 
Within the T cell population, although conventional αβ T cells are the primary T cell 
population present in human psoriasis lesion, IL-17 producing γδT and MAIT cells have also 
been implicated in human psoriasis (Laggner et al., 2011; Teunissen et al., 2014b), whereas 
IL-17 producing γδT cells are the primary pathogenic cells type in the imiquimod induced 
psoriasiform inflammation in the murine model (Cai et al., 2011). Recently, TCR sequencing 
of psoriasis lesional biopsies has also revealed distinct clonal signatures of γδ TCR (Harden 
et al., 2015a). 
4.1.2.4 In Search for the Autoantigens for Psoriasis 
Oligoclonal expansion of T cells has been found in psoriasis lesions (Chang et al., 1994; 
Menssen et al., 1995; Lin et al., 2001), and sampling from recurrent psoriasis lesions found 
retained clonal expansion in relapsing lesions that was absent in uninvolved skin from the 
same donors (Vollmer et al., 2001). Taken the prominent role of T cells in psoriasis 
pathogenesis and the genetic associations with the antigen presentation pathway (HLAC and 
ERAP1), a very obvious question is what antigen(s) T cells recognize in psoriasis and 
whether the response to autoantigen drives psoriasis pathogenesis. Many autoantigens have 
been proposed, some of which (e.g. Ezrin, Maspin) resemble peptides derived from 
streptococcus, supporting a molecular mimicry hypothesis (Besgen et al., 2010). Recently, 
LL37, the AMP triggered initial innate activation in psoriasis, was proposed to be an auto-
antigen (Lande et al., 2014). Thus, LL37 has putative roles in two distinct pathogenic 
mechanisms through activating pDCs and as a T cell antigen. Another recent report suggested 
that melanocyte protein ADAMTSL5 could trigger IL-17 production by CD8 T cells in 
human psoriasis (Arakawa et al., 2015). Nevertheless, the direct causal role of these 
autoantigens or autoreactive T cells in psoriasis has not been shown yet. 
4.1.3 Treatments 
Effective therapies that control the symptoms of psoriasis are available today and most of 
these treatments mediate their therapeutic effects through different forms of 
immunosuppression. In general, therapies for psoriasis can be classified as topical, 
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phototherapy and systemic therapy. Treatment is generally decided according to the severity 
of the disease. Topical vitamin D analogues and glucocorticoids can be applied on affected 
skin of patients and promote “local” immunosuppression. For patients with moderate to 
severe psoriasis affecting large areas of the skin, topical treatment is insufficient. Narrow-
band UVB (nb-UVB) phototherapy is typically the next choice of therapy for patients where 
topical therapies are not effective and nb-UVB is often used together with vitamin D 
analogues. The exact mechanism of the therapeutic effect of nb-UVB is likely to be the 
mixed effects of induction of apoptosis in skin cells (keratinocytes and immune cells) and 
immunosuppression by lowering transcription of inflammatory cytokines (Ozawa et al., 
1999; Walters et al., 2003). Cyclosporine, targeting Calcineurin, and Methotrexate, limiting 
cell division by inhibiting folic acid metabolism, are systemic treatments that are used to treat 
moderate to severe psoriasis patients (Heydendael et al., 2003). 
Biologic agents that target molecules involved in the pathogenesis of psoriasis have 
revolutionized the treatment for patients with severe psoriasis during the last decade. TNF 
antagonists including Infliximab, Etanacept and Adalimumab, and anti-IL-12/23p40, 
Ustekinumab, are effective treatments, which highlight key role of TNF and IL-12/23 in 
psoriasis pathogenesis (Lowes et al., 2007). Anti-IL-23p19, Guselkumab, and Tildrakizumab, 
show promising results in recent clinical trials (Gordon et al., 2015; Papp et al., 2015), and 
Secukinumab, an IL-17A monoclonal antibody is already approved for treatment of psoriasis 
and psoriatic arthritis with Ixekizumab directed against the same target follows closely 
behind (Langley et al., 2014; Griffiths et al., 2015; Mease et al., 2015). Together these drugs 
further verify the central role of IL-23/Th17 axis in psoriasis. The development of biological 
agents has significantly improved the treatment options for moderate to severe psoriasis 
patients, but considering the logistic and cost of biologic agents, there is still a need for 
alternatives. Small molecules for oral use are currently being developed. Apremilast, 
inhibiting PDE4, an enzyme breaking down cyclic adenosine monophosphate (cAMP), is 
already approved and widely used (Poole and Ballantyne, 2014). Tofacitinib, a JAK1/3 
inhibitor, showed promising therapeutic effect in a clinical trail and may provide more 
options to moderate to severe patients in the future (Bachelez et al., 2015). Nonetheless, all of 
these immunosuppressive treatments may cause adverse effects like infection and 
malignancies, due to their immunomodulatory effects. 
4.1.4 Molecular Scar of Resolved Psoriasis 
Although effective treatments are available for psoriasis and results in suppression of 
inflammation, resolution of epidermal thickness and clinical remission, psoriasis cannot be 
cured (Clark, 2011). Psoriasis often recurs at site of the previous lesions upon withdrawal of 
treatment, indicating the existence of “localized disease memory". Krueger and colleagues 
addressed this question by following patients treated with etanercept and found a set of up-
regulated genes related to T cells and inflammatory cytokines remaining in successfully 
treated lesion as compared to uninvolved skin after three months of anti-TNF therapy 
(Suárez-Fariñas et al., 2011). This proposed “molecular scar” may form the basis of the 
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“localized disease memory” underlying the recurrence of psoriasis in previous lesions 
(Suárez-Fariñas et al., 2011) and TRM cell has been proposed to be involved in forming site 
specific disease memories (Clark, 2011). The role of TRM cells in “localized disease memory” 
in resolved psoriasis is examined in this thesis (Figure 4.4). 
 
Figure 4.4. Schema of proposed  “localized disease memory” in resolved psoriasis.  
Upon healing by successful treatment, pathogenic memory T cells reside in the epidermis of resolved lesion. 
Upon re-stimulation, these memory T cells will be activated in situ; thereby, giving rise to a local inflammatory 




Vitiligo is an acquired chronic disorder of the skin that affects 0.5-
1% of the population with equal incidence in men and women 
(Ezzedine et al., 2015). Vitiligo is characterized by depigmented 
macules (Figure 4.5) as a result of local loss of melanocytes in 
affected patches of the skin. Half of the patients develop the disease 
before 20 years of age (Majumder et al., 1993) and vitiligo is often 
associated with other autoimmune diseases: Addison’s disease, 
autoimmune thyroid disease, type I diabetes mellitus, alopecia 
areata and psoriasis (Rezaei et al., 2007; Sheth et al., 2013). 
4.2.1 Genetics 
Vitiligo can run in families indicating a strong genetic predisposition to the disease. A study 
showed that the concordance of vitiligo in monozygotic twins is 23% while 6-8% of 
probands’ first-degree relatives of patients also have vitiligo (Alkhateeb et al., 2003). The 
relative risk of vitiligo has been estimated 13 -18 times higher in patients’ first-degree 
relatives as compared to the general population (Alkhateeb et al., 2003). Genetic associations 
between different HLA alleles with vitiligo were not consistent with HLA-A2, DR4, and DR7 
being reported as susceptible HLAs in different ethnic groups (Rezaei et al., 2007; Tarlé et 
al., 2014). GWAS identified tyrosinase, TYR, as the key susceptible gene of vitiligo (Jin Y et 
al., NEJM, 2010). Tyrosinase is a key enzyme in melanin synthesis and is one of the 
proposed autoantigen in vitiligo (Song et al., 1994; Ezzedine et al., 2015). The majority of 
Figure 4.5. Vitiligo.  
Courtesy of Dr. Jakob 
Wikström 
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other genes associated with vitiligo identified from the GWAS were primarily involved in 
inflammation or immune responses (e.g. PTPN22, IL2RA, GZMB, FOXP3, CD80, CCR6, 
NLRP1, IFIH1, TRIF, CASP7, and C1QTNF6.) (Jin et al., 2010; Spritz, 2012). However, 
with only 23% disease concordance in monozygotic twins indicates other factors also play a 
role in the pathogenesis. 
4.2.2 Pathogenesis 
The etiology of vitiligo is complex and not fully understood. The pathology of vitiligo is 
characterized by the loss of melanocytes in the epidermis. The oxidative stress theory of the 
pathogenesis of vitiligo provided certain insights on the biology of melanocytes, pathogenesis 
of vitiligo and possible environmental link to the disease. According to the oxidative stress 
theory, during melanin synthesis, quinones and indoles intermediate products are generated 
and the accumulation of these intermediates induce reactive oxygen species formation, which 
could lead to apoptosis of melanocytes (Boissy and Manga, 2004; Kroll et al., 2005) (Figure 
4.6 A). However, GWAS identified susceptible genes that predominantly suggested vitiligo 
as an autoimmune disease (Jin et al., 2010; Spritz, 2012). 
Serologic evidence showed that autoantibodies, capable of binding to melanocytes circulate 
in the serum of vitiligo patients; these autoantibodies were used to identify several vitiligo 
autoantigens, for example, tyrosinase, TRP-2, SOX-10 and melanin concentrating hormone 
receptor (MCHR) (Song et al., 1994; Kemp et al., 2007; Waterman et al., 2010). Antibodies 
from vitiligo patients are capable of binding to melanocytes; mediating antibody-dependent 
cellular cytotoxicity (ADCC); and inducing HLA-DR, ICAM1, and IL-8 expression by 
blocking MCHR, facilitating the immune response against melanocytes (Norris et al., 1988; 
Gilhar et al., 1995; Gottumukkala et al., 2006; Kemp et al., 2007) (Figure 4.6 A). 
Figure. 4.6 Schematic drawing of pathogenic mechanisms in vitiligo. (A) Loss of melanocytes is the 
hallmark of vitligo pathology. This can be triggered by different mechanisms. Oxidative stress may lead to 
apoptosis of melanocytes; autoantibodies targeting melanocytes may promote inflammation or kill melanocytes 
by antibody-dependent cellular cytotoxicity (ADCC); cytotoxic CD8 T cells may kill melanocytes through target 
killing or induce apoptosis of melanocytes by IFN-γ. (B) Illustration of T cell infiltration in vitiligo lesion. 
 
In parallel with the antibody response, T cell-mediated cellular immune response is also 
implicated in the pathogenesis of vitiligo. Tyrosinase, Melan-A (MART1), and gp100 have 
been identified as T cell autoantigens in vitiligo (Palermo et al., 2005; Oyarbide-Valencia et 
al., 2006) and a high frequency of melanocyte-specific skin homing CD8 T cells can be 
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found in peripheral blood of vitiligo patients (Ogg et al., 1998). Immune cells including 
macrophages, CD4, and CD8 T cells, infiltrate the perilesional vitiligo skin but not the non-
lesional skin from vitiligo patients, providing evidence for a localized immune response (van 
den Wijngaard et al., 2000). Higher density of perforin or granzyme B expressing cells 
populate the perilesional skin in close proximity to disappearing melanocytes, compared to 
the central part of individual lesions, non-lesional or control skin from non-affected 
individuals (van den Wijngaard et al., 2000) (Figure 4.6 A.B). Furthermore, T cells isolated 
from the perilesional skin of vitiligo can target and kill autologous melanocytes (van den 
Boorn et al., 2009; Wu et al., 2013). Lately, a mouse model of vitiligo identified IFN-
γ/CXCL10 pathway as the key pathogenic pathway (Harris et al., 2012; Rashighi et al., 
2014). IFN-γ was shown to reduce proliferation and to induce apoptosis in melanocytes 
(Yang et al., 2015); and the IFN-γ induced downstream chemokine CXCL10 was implicated 
in recruitment of T cells into vitiligo lesions (Rashighi et al., 2014) (Figure 4.6 A.). Induced 
recruitment of Tregs in spontaneous vitiligo mouse model showed reduced depigmentation, 
suggesting a regulatory role of Treg in vitiligo (Eby et al., 2015). In addition, Treg induced 
anergy of self reactive CD8 T cells targeting vitiligo antigen (Maeda et al., 2014).  
4.2.3 Treatments 
As compared to psoriasis, vitiligo patients have limited treatment options. Melanocytes renew 
locally in the skin, and the bulge area of the hair follicles act as a reservoir of melanocyte 
precursors (Cui et al., 1991). Successful vitiligo treatments do not only require suppression of 
the immune response but also the repopulation of melanocytes to affected skin from these 
reservoirs. Hairless skin or skin with depigmented hairs cannot repigment by medical 
treatment and may require surgical grafting of autologous skin or transplant of cultured 
melanocytes (Shaffrali and Gawkrodger, 2000). Topical immunomodulatory drugs such as 
calcineurin inhibitors (tacrolimus and pimecrolimus) and corticosteroids are first-line vitiligo 
treatments. Phototherapy with nb-UVB can trigger proliferation of melanocyte precursors 
(Goldstein et al., 2015) and is often combined with application of topical agents like steroids 
and vitamin D analogues (Shaffrali and Gawkrodger, 2000; Taieb et al., 2012). Systemic 
steroid treatment, cyclosporine or anti-TNF show limited effect in inducing effective 
repigmentation (Taieb et al., 2012).  
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5 AIMS 
This thesis aims to study the functional properties of tissue-resident memory T (TRM) cells in 
healthy human skin and in two immune-mediated skin diseases, psoriasis and vitiligo.  
The specific objectives are: 
• To dissect the functional heterogeneity of skin resident T cells in healthy skin and 
vitiligo lesions (PAPER I); 
• To investigate the potential role of skin resident T cells in the proposed localized 
disease memory in psoriasis (PAPER II); 
• To explore proinflammatory properties of granzyme A in psoriasis pathology 
(PAPER III); and 
• To study the genetic association of IL22 promoter in psoriasis by stratification for age 
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6 MATERIALS AND METHODS 
Tissue samples (PAPER I, II, III, IV) 
Healthy skin samples were obtained from reconstructive surgery at the AdVita Clinic at St. 
Göran Hospitial (Stockholm, Sweden) (PAPER I-III) or the reconstructive surgery 
department at Karolinska University Hospital (Stockholm, Sweden) (PAPER I). Four 
milimeters punch biopsies (one to five per individual) were obtained from the trunk or thighs 
under local anaesthesia from plaque psoriasis patients recruited from either psoriasis 
association (Sundyberg, Sweden) or Dermatology Department at Karolinska University 
Hospital (Stockholm, Sweden) (PAPER II,III). Previous psoriasis lesions upon clinical 
remission were located by photos taken at times of active disease, reliable clinical 
information, or post-inflammatory hyperpigmentation (PAPER II). Patients in the genetic 
study (PAPER IV) were diagnosed with psoriasis after clinical examination by a 
dermatologist at the department of Dermatology, Karolinska University Hospital, Stockholm, 
Sweden or at the Swedish Psoriasis Association, Gothenburg, Sweden. Vitiligo patients were 
recruited from the Vitiligo Patient Association in Sweden and the Dermatology Department 
at Karolinska University Hospital (Stockholm, Sweden). Lesional biopsies were sampled 
from within 1 cm to the edge of depigmented lesion border. Non-lesional biopsies were taken 
at least 10 cm away from depigmented lesions.  
All studies were approved by Stockholm Regional Committee of Ethics and performed 
according to the Declaration of Helsinki Principles. For patients below 18 years of age from 
PAPER IV, parental written consent was obtained. Ethical Permits:  PAPER I: 2012/50-
31/2; amendment: 2015/0041-31,2015/933-32, 2012/1900-31/1, 2013/1800-32; amendment: 
2015/1078-32. PAPER II: 2005/977-31/3, 2007/20-31/2, 2012/50-31/2. PAPER III: 
2012/50-31/2. PAPER IV: 99-296, 02-241, amendment 02-241 - 2011/1601-32, 03-198 
Genetic analysis (PAPER III) 
The IL22 promoter in 12 psoriasis patients was sequenced using ABI3730 (Applied 
Biosystem) according to manufacturer’s protocols. Putative binding sites for AhR-ARNT 
complex were identified by RAVEN (http://www.cisreg.ca/cgi-bin/RAVEN/a) and TFBIND 
(tfbind.hgc.jp). Single nucleotide polymorphisms (SNPs) (rs12307915, rs2227473, and 
rs2227483) were typed with TaqMan SNP Genotyping assay (Applied Biosystems). And the 
INDEL, rs35774195/rs10784699 (AT/-) was typed with customized TaqMan Genotyping 
assay with one probe bound with the sequence with AT insertion and the other probe without 
the AT insertion. The SNP rs10784699 was imputed from the genotype of rs2227477. 
Cell culture  
Cells were cultured at 37°C, 5% CO2. For Peripheral blood mononuclear cells (PBMCs), 
skin cell suspensions and sorted T cells, cells were cultured in Complete Medium: Roswell 
Park Memorial Institute medium (RPMI) 1640 supplemented with GlutaMAX™-I, 10% 
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Fetal Bovine Serum (FBS) (Hyclone) and 100U/mL Penicillin-streptomycin (PEST) (all from 
Life Technologies). P815 cell were courtesy of Dr. Yenan Brycesson, Center for infectious 
medicine, Huddinge. HeLa cells were courtesy of Dr. Ning Xu, Center for molecule 
medicine, Solna.  
Keratinocyte culture and stimulation (PAPER IV) 
Four mm punch biopsies were incubated in 5U/mL dispase (life technologies) overnight at 
4°C. Epidermis was manually separated from dermis and incubated in 0.05% Trypsin/ 
Ethylenediaminetetraacetic acid (EDTA) (Life Technologies) at 37°C for 30 min. 10% FBS 
in Dulbecco's Modified Eagle Medium (DMEM) was added to the cells to inhibit trypsin 
digestion. Cells were washed and resuspended in EpiLife medium supplemented with Human 
Keratinocyte Growth Supplement (HKGS), 100 U/mL penicillin/streptomycin and 1% 
Fungizone (all from Life Technologies), and plated in dishes pre-treated with collagen 
(VWR). The keratinocytes were passaged twice and then cryopreserved for further use. 
Thawed human keratinocytes were seeded in EpiLife/HKGS/PEST/Fungizone medium in a 
24-well plate at a density of 40000 cells/well/mL and left to recover for 24 hrs. A final 
concentration of 35nM GrzA (Enzo Life Sciences), 10ng/mL IL17A (R&D) or a combination 
of both was prepared in medium excluding HKGS. Keratinocytes were washed with PBS 
before adding 0.5 mL of each culture mix in triplicates. After 48 hours of incubation at 37°C 
the supernatants were collected and immediately put on dry ice and then stored at -80°C. 
Preparation of cell suspension from tissue samples (PAPER I, II, III) 
Whole skin biopsies were placed in 5U/mL dispase (Life Technologies) overnight at 4 ̊C and 
epidermis was manually separated from dermis. Epidermis was cut into small pieces. In 
PAPER I, II (Figure 5,6) and PAPER III, both epidermis and dermis were digested with 
collagenase III (3 mg/ml; Worthington) for 90 min with DNase (5 mg/ml) in complete RPMI 
1640 medium. In PAPER II (Figure 1-4), epidermis was placed in trypsin (0.025%)/EDTA 
(0.01%) (Life Technologies) for 15 min at 37°C. Epidermal single-cell suspension was 
prepared by repeated pipetting. The digested tissue suspensions were then diluted with 5-10 
times volume of complete medium, 70-µm filtered, centrifuged and resuspended in complete 
medium for further experiments. PBMCs were prepared by Ficoll Plaque (GE Healthcare) 
gradient isolation. For cell sorting for cytotoxicity or functional assays, a relatively large 
number of T cells was required. Epidermal sheets were placed in complete RPMI medium 
with or without IL-15 (20ng/mL, R&D System) for 48 hours to allow cell migration out of 
the tissue. Cells in explant culture would consist of relatively enriched lymphocytes 
populations.  
Flow Cytometry (PAPER I, II, III, IV) 
In PAPER II and IV, cell suspensions were stained with Live/Dead Yellow Kit (Invitrogen) 
and, subsequently, the surface staining was performed with a cocktail of fluorochrome-
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conjugated Abs at 4°C for 30-40 min. In PAPER I and III, both Live/Dead Yellow Kit 
(Invitrogen) staining and surface staining were done in the same step at 4°C for 30-40 min. 
For phenotypic analysis, cell suspensions were kept in complete medium for 18 hours. For 
some intracellular cytokine staining, cell suspensions were stimulated with phorbol 12-
myristate 13-acetate (PMA) (50 ng/ml) and ionomycin (1 µg /ml) for 5 hours in the presence of 
brefeldin A (BD Biosciences) in the last 4 hours of stimulation following the manufacturer’s 
protocols. BD Cytofix/Cytoperm Kit (BD Bioscience) was employed for the fixation and 
permeabilisation for intracellular staining of cytokines and cytotoxic granule constituent 
proteins according to manufacturer’s protocols. Stained cells were acquired by a CyAn ADP 
analyzer (Beckman Coulter), LSR-II (BD Biosciences) or LSRFortessa flow cytometer (BD 
Biosciences), and analyzed using Flowjo (Tree Star). In PAPER II, the number of cells was 
quantified by the density of cells in unit surface area of skin and presented as “number of 
cells/mm2”. 
Cytokine stimulation on cell suspension (PAPER I) 
Epidermal cell suspensions were plated at 1-2 million cells/well in a 6-well plate and 
incubated with IL-15 (20ng/mL), IL-1β (20ng/mL), IL-6 (20ng/mL), IL-23 (20ng/mL), IL-7 
(20ng/mL), IL-12 (50ng/mL), Type I IFN (2000U/mL) (all from R&D system) or medium 
only in the final volume of 4mL for 48 hours. Cells were passed through a 70-µm cell strainer 
before staining for flow cytometry. 
Cell sorting (PAPER I, II) 
For RNA and DNA extraction from specific population of cells, cell suspensions were stained 
for surface antigens immediately after preparation and sorted at Department of Microbiology, 
Tumor and Cell Biology in Karolinska Institutet using MoFlo XDP (Beckman Coulter) cell 
sorter. Stained cells were kept on ice before sorting. For RNA extraction, cells were sorted 
directly into Qiazol (Qiagen) and stored at -80°C for later RNA extraction. For DNA 
extraction, cell were sorted directly into cell lysis solution (Qiagen, Puregene Kit) and stored 
at room temperature before DNA extraction according to manufacturer’s protocols. For 
functional and cytotoxicity assays in PAPER I, cells collected from explant culture were 
stained at 4°C and kept on ice before sorting. The sorting was performed on a BD 
FACZJAZZ at the Unit of Translational Immunology, Karolinska University Hospital. Cells 
were sorted into RPMI with 50% FBS at kept at 4°C. Cells were placed in complete medium 
overnight at 37°C before further experiments. 
RNA purification and quantitative RT-PCR (PAPER I) 
RNA was purified using miRNeasy Mini Kit (Qiagen) and reverse transcribed by High 
Capacity cDNA Reverse Transcription Kits (Applied Biosystems). The quantitative RT-PCR 
was performed using TaqMan PreAmp Master Mix Kit (Applied Bioscience) and the 
TaqMan Gene Expression Master Mix (Applied Bioscience) with custom-made TaqMan 
Low density array (TLDA) plates pre-coated with TaqMan assays (see below) following the 
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manufacturers’ protocols. Relative expression value was calculated as: 2-ΔCT, with beta-2 
microglobulin (B2M) being the house-keeping gene.  
AXIN2-Hs00610344_m1 GAPDH-Hs99999905_m1 ITGA1-Hs00235006_m1 
B2M-Hs00984230_m1 GATA3-Hs00231122_m1 ITGAE-Hs01025372_m1 
BCL2-Hs00608023_m1 GZMA-Hs00989184_m1 KLRG1-Hs00929964_m1 
BCL6-Hs00277037_m1 GZMB-Hs01554355_m1 KLRK1;KLRC4-KLRK1-Hs00183683_m1 
CCR6-Hs01890706_s1 ID2-Hs00747379_m1 PDCD1-Hs00169472_m1 
CD207-Hs00210451_m1 ID3-Hs00171409_m1 PRDM1-Hs00153357_m1 
CD3E-Hs01062241_m1 IFNG-Hs00989291_m1 PRF1-Hs00169473_m1 
CD4-Hs00181217_m1 IL10-Hs00961622_m1 RORC-Hs01076122_m1 
CD68-Hs00154355_m1 IL15RA-Hs00542604_m1 SELL-Hs00174151_m1 
CD8A-Hs00233520_m1 IL17A-Hs00174383_m1 TBX21-Hs00203436_m1 
CRLF2-Hs00845692_m1 IL2-Hs00174114_m1 TCF7-Hs00175273_m1 
CTLA4-Hs03044418_m1 IL21R-Hs00222310_m1 TCF7L1-Hs01064103_m1 
EOMES-Hs00172872_m1 IL22-Hs01574154_m1 TCF7L2-Hs01009044_m1 
FAS-Hs00236330_m1 IL2RA-Hs00907779_m1 TGFB1-Hs00998133_m1 
FASLG-Hs00181225_m1 IL2RB-Hs01081697_m1 TNF-Hs00174128_m1 
FOXP3-Hs01085834_m1 IL7R-Hs00902334_m1 TNFSF10-Hs00921974_m1 
Table:  Assays on TaqMan Low density array (TLDA). 
RNA-seq (PAPER II) 
Extracted RNA was stored at -80°C. Concentration and integrity of RNA was checked with a 
Bioanalyzer using RNA 6000 Pico Kit (Agilent) before library construction using SMART-
Seq v4 Ultra Low Input RNA Kit (ClonTech) and sequenced by Illumina HiSeqTM 2000, at 
Beijing Genomic Institute, Hong Kong. RNA-seq analysis was performed using RStudio. 
Differential gene expression analysis was performed using EdgeR package (Robinson et al., 
2009) on Bioconductor using rounded expected read count data by RSEM (Li and Dewey, 
2011). CD103+CD49a+ and CD103+CD49a- TRM cells from the same donor were paired. 
Likelihood ratio test was used to calculate p-values and false discovery rate (FDR) method 
was employed to correct for multiple comparisons. Gene Enrichment analysis was performed 
by DAVID bioinformatics tool (Huang et al., 2009). 
TCR-seq (PAPER II) 
DNA was extracted by using Puregene Kit (Qiagen). Extracted DNA was stored at -20°C and 
sent to Adaptive Biotechnogies, Seattle, US, for ImmunoSEQ analysis. The TCR Vβ CDR3 
region was sequenced with the ImmunoSEQ platform (Robins et al., 2009; Robins, 2013). 
Non-productive sequences were omitted from the data analysis. 
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Functional assay on sorted T cells (PAPER II) 
Sorted CD8 T cell subpopulations were resuspended and kept in complete RPMI medium 
overnight at 37°C before use.  5000-10000 cells were plated per well on 96-well V-bottom 
plates. For time-course experiment, cells were stimulated with IL-15 (20ng/mL) for 1, 2, 4, 8 
and 48 hours.  Actinomycin-D (Act-D, 5µg/mL) was added prior to IL-15 to inhibit de novo 
synthesis of mRNA in the transcriptional blocking group. For antigenic stimulation, sorted 
CD8 T cells plated in the same way were cultured with P815 cells in 1:1 ratio with the 
presence of anti-CD3 (1µg/mL, OCT-3) and brefeldin A (1:1000, BD) for 5 hours at 37°C. 
Cytotoxicity assay (PAPER II) 
Sorted CD8 T cell subpopulations were resuspended and kept in complete RPMI medium 
overnight at 37°C before use as effector cells in cytotoxicity assay. The cytotoxic assays were 
performed at the Center of Infectious Medicine, Karolinska University Hospital, Huddinge, 
as described in (Chiang et al., 2013). Effector cells were incubated with 2000 51Cr-labelled 
P815 cells with 0.5µg/mL of anti-CD3 (clone S4.1) with the effector-to-target cell ratios 
ranged from 10 to 0.3, and incubated for 4 hours at 37°C. 51Cr release in supernatant was 
measured as count per minute (cpm) on a γ-counter (Wizard2, PerkinElmer). Specific lysis 
was calculated as (mean experimental cpm – mean spontaneous cpm) / (mean maximum cpm 
– mean spontaneous cpm) x 100. 
Confocal microscopy (PAPER I) 
Cryosections (12µm) from frozen skin biopsies were fixed by acetone and then stained with 
primary Antibodies at 4°C overnight and then with secondary antibodies conjugated to Alexa 
Fluor dyes (Invitrogen) for 15 min in room temperature. Nuclei were stained with DAPI 
(Sigma-Aldrich) for 1 min. Images were acquired with a laser scanning confocal microscopy 
(LSM700) with Zen 2011 software (Zeiss) and analyzed with ImageJ 
(http://imagej.nih.gov/ij/). 
Luciferase assay (PAPER III) 
In PAPER III, a luciferase assay was employed to determine whether promoter with high-
risk or low-risk variants would affect the transcriptional activity of IL22. HeLa cells were 
seeded onto 96-well plates (104 cells per well) and cultured at 37°C in DMEM supplemented 
with 10% FBS, 100 U/ml and 1X penicillin/streptomycin (Invitrogen, Stockholm, Sweden) 
one day before transfection. Luciferase construct with either the high-risk IL22 promoter 
(rs2227473 (A), INDEL (AY)) or the low-risk promoter (rs2227473 (G), INDEL (–)) were 
synthesized and cloned into pGL3 basic vector by GenScript (Piscataway, NJ). HeLa cells 
were transfected with the firefly luciferase reporter plasmids (100ng per well) together with a 
renilla luciferase reporter (5ng/well) plasmid as internal control. All transfections were 
carried out by Fugene HD (Promega, Stockholm, Sweden) following the manufacturer’s 
protocol, in antibiotics free DMEM medium with 10% FBS. Transfected cells were left in 
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complete DMEM medium for 12 hours before PMA (50 ng/ml, Sigma Aldrich) treatment for 
24 hours in six replicates. Luciferase activity was analyzed by using Dual Luciferase 
Reporter Assay System (Promega) following the manufacturer’s instruction. Relative 
luciferase activity was determined by the ratio of luciferase signal at 24-hours after PMA 
treatment to the luciferase signal prior stimulation. 
Statistical analysis (PAPER I, II, III, IV) 
Mann-Whitney U test or two-tailed Wilcoxon matched-pairs signed rank test were generally 
used to determine statistical significant of flow cytometry or qRT-PCR data points from 
independent or paired samples. Two-sided Student’s T test was used to determine statistical 
significance within single experiment with triplicates or more. P-values were corrected for 
multiple testing by Holm–Bonferroni method. Detailed statistical analysis for genetic study 
can be found in PAPER IV. Statistic analysis and graphical presentation were computed 
using PRISM 6 (GraphPad) software.  
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7 RESULTS 
7.1 Healthy Human Skin Contains a Heterogeneous Population of T Cells. 
In PAPER I, we studied the composition of skin-resident T cell populations in epidermis and 
dermis from healthy individuals. Peripheral blood was also obtained from paired donors for 
comparison. Consistent with previous findings (Foster et al., 1990; Spetz et al., 1996), the 
majority of T cells in the skin, both epidermal and dermal, were αβ T cells. The proportion of 
γδ T cells among the whole T cell population in healthy skin was generally lower in the 
epidermis (2.2% ± 2.1) and dermis (2.2% ± 1.8), than the proportion of γδ T cells in the 
circulation (4.7% ± 2.7)  (Figure R1. A-D). It has been suggested that CD8 T cells primarily 
home to epidermis while CD4 T cells localized in the dermis of human skin (Nestle et al., 
2009a) but inconsistent CD4:CD8 T cells ratio in epidermis has been reported, ranging from 
absolute dominance of CD8 T cells to a 2:1 , CD4:CD8, ratio (Bos et al., 1987; Foster et al., 
1990; Spetz et al., 1996). Our data suggested a slight dominant of CD4 T cells over CD8 T 
cells in the epidermis and dermis (Figure R1.E). We further characterized the classical 
memory phenotype of skin-resident T cells in healthy skin according to their CD62L and 
CD45RA expression, and found that CD8 T cells from skin comprise mostly TEM (CD45RA-
CD62L-) or TEMRA (CD45RA+CD62L-) phenotypes, while CD4 T cells displayed mainly a 
TEM phenotype with a smaller proportion of CD4 T cells expressing CD62L, i.e. TCM 
phenotype (CD45RA-CD62L+), in epidermal and dermal T cells (Figure R1). 
 
Figure R1. Characterization of major T cell populations in healthy human skin. 
(A-C) Proportion of γδ T cells, CD4 T cells and CD8 T cells among total CD3+ T cells population within 
epidermis, dermis and peripheral blood from healthy donors. (D) Proportion of γδ T cells among total CD3+ T 
cells population within epidermis, dermis and peripheral blood from healthy donors. Wilcoxon test on paried 
samples. (E) CD4 to CD8 T cell ratio in epidermis, dermis and peripheral blood from healthy donors. Lines 
indicate median of the data in scattered dots plots (n=20). (F-H) Proportion of naive T cells (Tnaive), central 
memory TCM, TEM and TEMRA T cells among total CD4+ or CD8+ T cells population within epidermis, dermis and 
peripheral blood from healthy donors. Mean +/- SD (n=14) is depicted in bar charts. * p<0.05, ** p<0.01, *** 
p<0.001. 
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Mouse studies demonstrated that expression of TRM cell surface markers, CD103 and CD69, 
identified majority, if not all, of the non-recirculating resident T cells in non-lymphoid 
epithelial tissues (Gebhardt et al., 2009; Steinert et al., 2015). In humans, expression of 
CD103 and CD69 has previously been used for characterizing TRM cells in the lung, intestine 
and skin tissues (Sathaliyawala et al., 2013; Thome et al., 2014; Watanabe et al., 2015). In 
healthy skin, Watanabe et al. showed that epidermis contained a large proportion of 
CD103+CD69+ TRM cells, whereas dermis consisted a slightly higher proportion of CD103-
CD69+ TRM cells as compared to the CD103+CD69+ TRM cells (Watanabe et al., 2015). In 
agreement with Watanabe at al., we found CD103 and CD69 expressing CD4 or CD8 T cells 
highly enriched in the epidermis and to a lesser extent in the dermis as compared to the 
circulating T cells (Figure R2). The majority of epidermal CD8 T cells (53.0% ± 17.8) co-
expressed CD103 and CD69 while less than 10% of dermal CD8 T cells co-expressed both 
markers (6.0% ± 3.1) (PAPER I, Figure 1). Similar CD103 and CD69 expression patterns 
were observed in skin-resident CD4 T cells, with a lower proportion (38.8% ± 11.0) in the 
epidermal population co-expressing CD103 and CD69 as compared to their CD8 
counterparts. CD49a is another marker found to be expressed in virus-specific TRM cells in 
the skin and lung (Gebhardt et al., 2009; Piet et al., 2011). In human skin, Purwar et al. found 
that only 15% of total T cells expressed CD49a after a 4-week explant culture (Purwar et al., 
2011). Our data showed that CD49a expression was restricted in epidermal CD8 T cells, 
particularly within the CD8+CD103+CD69+ TRM cell subset in the healthy human skin (Figure 
R2 C, D).  However, a high variation of CD49a expression was noted among healthy donors 
ranging from 0 to 70% of CD8 T cells (Figure R2.C, D; PAPER I, Figure. 1). Sequencing 
analysis of the CDR3 region of TCRβ on sorted TRM cell subpopulations from 5 individuals 
revealed reduced clonal diversity and enrichment of dominant clonotypes in epidermal 
CD8+CD103+CD49a+ TRM cells as compared to CD8+CD103+CD49a- TRM cells, dermal T 
cells and circulating TEM cells (PAPER I Figure 2) implicating a possible previous clonal 
expansion of the CD8+CD103+CD49a+ TRM cells. 
 
Figure R2. Characterization of TRM cell surface markers’ expression in T cells from healthy skin. 
(A-C) Proportion of CD103+ (A), CD69+(B) and CD49a+(C) among CD4 or CD8 T cells from epidermis, dermis 
and peripheral blood from healthy donors. (D) Proportion of CD49a+ among CD8 T cells subsets defined by 
their CD69 and CD103 expression. Wilcoxon test, corrected for mutliple comparison (n=20) *** p<0.001, ** 
p<0.001, n.s. depicted not significant. 
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Taken together, we found that heterogeneous populations of CD4 and CD8 T cells resided in 
both epidermis and dermis of the healthy human skin. TRM cells expressing both CD103 and 
CD69 were highly congregated in the epidermis. Interestingly, a minor population of CD4 T 
cells present in both epidermis and dermis expressed CD62L that may imply a recirculating 
capacity. In resolved murine cutaneous HSV infection, virus-specific resident CD4 and CD8 
T cells are often localized in different regions of the skin. CD8 TRM resided in the epithelia, 
with confined mobility; whereas CD4 T cells localized in the dermis, rapidly trafficking 
between skin tissue and circulation (Gebhardt et al., 2011). Identification of migratory T cell 
subsets in healthy human skin and cutaneous lymphomas provided further support for a 
recirculating T cell subset within the skin (Watanabe et al., 2015). Our results highlighted the 
specific expression of CD49a in a subset of CD8+CD103+CD69+ TRM cells. By understanding 
the basic function of different TRM cell subpopulations in the skin, we aimed to further 
elucidate their clinical implication in skin diseases. 
7.2 CD49a Marks Functionally Distinct CD8 TRM Cells in Healthy Skin 
The high variation in the frequency of CD8+CD103+CD49a+ TRM cells in the healthy skin led 
us to postulate that CD8+CD103+CD49a+ TRM cells might be functionally distinct from their 
CD49a- counterparts in the healthy epidermis. Indeed, epidermal CD8+CD103+CD49a+ and 
CD8+CD103+CD49a- TRM cells exhibited differential cytokine-producing capacity. In 
PAPER I, IFN-γ and IL-17A production capacity in different subpopulations of skin resident 
T cells were assessed upon PMA and ionomycin stimulation of the whole epidermal or 
dermal cell suspension (PAPER I, Figure 1). No strong preference was found in IFN-γ and 
IL-17 production between CD4+CD103+ and CD4+CD103- T cells (PAPER I, Figure 1). On 
the contrary, epidermal CD8+ TRM cell subpopulations displayed distinct cytokine expression 
patterns: IL-17A was expressed in CD8+CD103+CD49a- T cells in both epidermis and 
dermis, whereas CD8+CD103+CD49a+ epidermal TRM cells preferentially produced IFN-γ 
(PAPER I, Figure 1). Therefore, a clear functional dichotomy of epidermal CD8+CD103+ 
TRM cells distinguished by their CD49a expression was unveiled.  
PMA and ionomycin stimulation strongly induces Protein kinase C (PKC) activation and 
Ca2+ signaling in T cells (Smith-Garvin et al., 2009). This stimulation regimen is a great tool 
to study the functional potential of T cells but the activation bypass surface receptor ligation. 
A more physiological way to activate T cells would be to stimulate with their cognate antigen 
together with antigen presenting cells. However, such approach requires in-depth knowledge 
on what the population of interest recognises, which is difficult when using skin material 
from a heterogeneous population. To mimic TCR:MHC ligation, we employed an antibody 
re-directed functional assay in which P815 cells presented a stimulatory anti-CD3 Abs to 
sorted CD8+ CD103+ TRM cells, mimicking an antigenic stimulation. Although the frequency 
of cytokine expression is lower than PMA and ionomycin stimulation, epidermal CD8 T cells 
activation through anti-CD3 stimulation showed the same trend of cytokine response as the 
PMA and ionomycin stimulation (PAPER I, Supp. Figure. 1). In addition, pre-treatment with 
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IL-15 strongly enhanced both the IFN-γ production in CD8+CD103+CD49a+ cells and the IL-
17A production in CD8+CD103+CD49a- TRM cells (PAPER I, Supp. Figure. 1).  
To further explore the functional differences between TRM cell subpopulations, 
CD8+CD103+CD49a+ and CD8+CD103+CD49a- TRM cells were sorted for RNA-seq analysis. 
Transcriptome analysis by RNA-seq confirmed the differential cytokine expression capacity 
between the two subpopulations and further demonstrated chemokine-producing and 
cytolysis capacity in CD8+CD103+CD49a+ TRM cells (PAPER I, Figure 3). In spite of the 
strong indication of a cytotoxic function in CD8+CD103+CD49a+ TRM cells, profiling of the 
cytotoxic granule constituent protein expression by flow cytometry surprisingly showed 
unstimulated T cells from freshly isolated epidermal cell suspension were devoid of 
significant expression of perforin, granzyme A, and granzyme B (PAPER I, Sup. Figure 3). 
We reasoned that TRM cells residing in the healthy skin could be in a quiescent state and may 
require specific stimulation to acquire cytotoxic granule constituent protein expression. 
Indeed, IL-15 preferentially up-regulated granzyme A, B and perforin in 
CD8+CD103+CD49a+ TRM cells but not in CD8+CD103+CD49a- TRM cells (PAPER I, Figure 
4), verifying the cytotoxic potential implicated by the transcriptome analysis.  The cytotoxic 
capacity of IL-15 stimulated CD8+CD103+CD49a+ TRM cells was confirmed with an 
antibody-redirected Cr-release cytotoxicity assay (PAPER I, Figure 4).  What is intriguing is 
that CD8+CD103+CD49a+ TRM cells failed to elicit cytotoxic function without IL-15 
stimulation, emphasizing the role of IL-15 in regulating the cytotoxic function of TRM cells 
(PAPER I, Figure 4). 
7.3 Cytotoxic CD49a+ TRM Cells Accumulated in Vitiligo Lesions 
T cell-mediated cellular cytotoxicity is crucial in controlling viral infection, but could also 
cause pathology in autoimmunity by targeting self-antigens. In vitiligo, IFNγ-mediated 
pathology and cytotoxicity against melanocytes have been implicated (Le Poole et al., 2004; 
Harris et al., 2012; Ezzedine et al., 2015; Yang et al., 2015). In light of the functional 
division between CD8+CD103+CD49a+ and CD8+CD103+CD49a- TRM cells in the healthy 
skin, we sought to explore the potential implication of TRM cell in the pathogenesis of vitiligo. 
In PAPER I, we found that epidermal and dermal CD8 T cells with CD8+CD103+CD49a+ 
TRM cell phenotype amassed within the depigmented lesions of vitiligo patients as compared 
to pigmented skin of vitiligo patients or skin from healthy donors (PAPER I, Figure 5). 
Interestingly, T cells with CD8+CD103+CD49a+ TRM cell phenotype accumulated in the 
dermis of depigmented lesions of vitiligo patients, whereas these cells were virtually absent 
in dermis of healthy donors or non-lesional skin of vitiligo patients (PAPER I, Figure 5). 
Furthermore, a significantly larger proportion of dermal CD8 T cells from depigmented 
vitiligo lesions co-expressed perforin and granzyme B as compared to the healthy skin, 
implicating a cytotoxic role of dermal CD49a+ TRM cells in vitiligo (PAPER I, Figure 5). The 
presence of cytotoxic CD8+CD103+CD49a+ TRM cells might, thereby, target melanocytes in 
situ, and help to sustain the depigmented phenotype of vitiligo. 
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7.4 Active Psoriasis Lesions Consist of IL-17 and IL-22 Expressing Epidermal 
CD4 and CD8 T cells 
Psoriasis pathogenesis is characterized by hyperproliferation of keratinocytes and infiltration 
of inflammatory cells in the skin lesions. In PAPER II, we quantified the T cell infiltration 
and analyzed gene expression of sorted epidermal and dermal T cells from active psoriasis 
lesions. Massive infiltration of both CD4 and CD8 T cells was noted in both epidermis and 
dermis of active psoriasis lesion (PAPER II, Figure 1). Gene expression profiling of sorted T 
cells showed that the differential gene expression between lesional and healthy skin was 
mainly confined in the T cells from the epidermal compartment, whereas the dermal 
populations showed only moderate alteration of gene expression in psoriasis as compared to 
the healthy state (Figure R3). Epidermal CD4 and CD8 T cells from psoriasis lesions showed 
a similar pattern of gene expression – up-regulation of the inflammatory genes - as compared 
to T cells sorted from the healthy epidermis (Figure R3 A,D). In particular, epidermal T cells 
from active lesions expressed significantly higher gene expression in IL17A and IL22 as 
compared to T cells from healthy epidermis or lesional dermis (PAPER II, Figure 2). In 
accordance with gene expression data, intracellular cytokine expression analysis by flow 
cytometry confirmed that higher proportion of the epidermal CD4 or CD8 T cells expressed 
IL-17A and IL-22 in active lesions as compared to healthy skin (PAPER II, Figure 5); while 
only mild differences were noted in dermal T cells. In addition, comparisons of gene 
expression profiles between epidermal and dermal T cells revealed an interesting pattern in 
which epidermal T cells highly expressed inflammatory genes, whereas dermal T cell 
expressed a higher level of genes related to survival, cytokine receptors and Wnt signaling 
pathway (Figure R3 C,F).  
 
Figure R3. Lesional epidermal T cells displayed upregulated inflammatory gene expression 
(A-F) Gene expression comparison between of CD8 (A-C) or CD4 (D-F) sorted from epidermis or dermis of 
lesional or healthy skin, groups compared were indicated in the x-axis and y-axis. Relative expression was 
calculated as: 2-(CT(Target Gene)-CT(B2M)). Diagonal dashed lines depict 2-fold difference and diaponal soild lines 
depict equal expression. Vertical and horizontal dashed lines marked the arbitrary detection thresholds (relative 
expression = 0.0002) 
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7.5 Granzyme A Triggers Chemokine Expression In Inflammed Keratinocytes 
Apart from the notable inflammatory genes, IL17A and IL22, our gene expression profiling 
showed CD8 T cells from dermis and epidermis of psoriasis lesion had significantly higher 
expression of cytotoxic-related genes, GZMA, GZMB and PRF (PAPER II, Figure 2). 
Previous histological studies showed that the numbers of granzyme B or perforin-expressing 
cells were significantly higher in lesional psoriasis skin compared with normal skin, but 
lower than that in atopic dermatitis lesions or allergic contact dermatitis (Yawalkar et al., 
2001a; Yawalkar et al., 2001b). However, the cytotoxic role of granzymes in the 
pathogenesis of psoriasis is unclear, since keratinocytes from psoriasis lesions were shown to 
be resistant to apoptosis (Wrone-Smith et al., 1997). In PAPER III, we revealed that a high 
proportion of CD8 T cells in psoriasis lesion, both epidermal and dermal, expressed 
granzyme A but not granzyme B or perforin (PAPER III, Figure 1).  
Froelich and colleagues proposed that granzyme A is a noncytotoxic proinflammatory 
protease (Metkar et al., 2008; Pardo et al., 2009). Due to the high proportion of granzyme A 
expressing CD8 T cells in psoriasis lesion, we investigated the potential inflammatory effect 
of granzyme A on keratinocytes. Granzyme A treatment alone failed to trigger any cytokine 
or chemokine production in keratinocytes. However, when incubated together with IL-17A, 
granzyme A was able to enhance secretion of chemokines, CXCL1 (GROα), CXCL12 
(SDF1), and CCL4 (MIP-1β) (PAPER III, Figure 2). These results implicated a novel 
proinflammatory role of granzyme A on keratinocytes. The enhanced chemokine production 
may lead to further recruitment of more inflammatory cells. It has previously been shown that 
granzyme A treatment triggered IL-1, IL-6 or IL-8 secretion by other cell types, such as 
monocytes, fibroblasts and lung epithelial cells, (Sower et al., 1996; Metkar et al., 2008; 
Pardo et al., 2009). On the contrary, we showed that granzyme A specifically up-regulated 
chemokine expression in inflamed keratinocyte. Since large proportion of lesional CD8 T 
cells express granzyme A, these resident CD8 T cells may provide extra proinflammatory 
signals by granzyme A production. Given the prominent role of CD8 T cells in many 
inflammatory skin diseases, further study of the possible proinflammatory role of granzymes 
in other skin diseases would be of interest. 
7.6 Th22 and Tc17 Cells Reside In The Epidermis of Clinically Healed 
Psoriasis Lesions 
Psoriasis can be successfully treated but may relapse after withdrawal of treatment, and often 
at the previous site of inflammation. We and others hypothesized that a T cell-mediated 
localized disease memory may underlie this phenomenon (Clark, 2011; Suárez-Fariñas et al., 
2011) (PAPER II). To test this, we sampled and analyzed skin biopsies from patients who 
were successfully treated with narrowband (nb)-UVB, anti-TNF or anti-IL12/23 at sites of 
previous lesions. Upon successful treatment, the number of epidermal T cells in resolved 
lesions in all three treatment groups was normalized to the range of healthy skin (PAPER II, 
Figure 3). However, the number of epidermal CD8 T cells in resolved lesion of UVB treated 
patients was higher than their paired uninvolved skin (PAPER II, Figure 3). Gene 
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expressions of GZMA, GZMB, and PRF were fully resolved in CD8 T cells derived from both 
biologics and nb-UVB-treated resolved lesions (PAPER II, Figure 4). IL17A expression was 
also normalised in epidermal T cells from biologics treatment where residual expression was 
found in UVB treated patients (PAPER II, Figure 4). However, IL22 expression was not 
resolved in epidermal CD4 and CD8 T cells from both the biologics or nb-UVB treatment 
(PAPER II, Figure 4). Therefore, skin resident T cells in resolved lesions resembled normal 
skin with minimal residual inflammatory gene expression. 
Although transcriptional profile was largely resolved, the residual IL17A and IL22 gene 
expression in sorted epidermal T cells from resolved lesions hinted towards a potential 
difference in their cytokine production capacity as compared to the healthy skin. Thus, we 
determined the cytokine expression of T cells from resolved lesions. In accordance to gene 
expression analysis, a population of epidermal CD4 T cells consistently expressed IL-22 (i.e. 
Th22) upon PMA and ionomycin stimualtion in cell suspesion derived from the resolved 
lesions from all three treatments studied (PAPER II, Figure 5; Figure R4). Higher proportion 
of IL-17 expressing in epidermal CD4 T cells was also noted in nb-UVB treated and anti-IL-
12/23p40 treated lesions but not in anti-TNF treated lesion. In contrast, epidermal CD8 T 
cells showed higher IL-17A expression upon reactivation in all three studied treatments while 
IL-22 expression was only apparent in resolved epidermis from UVB treated patients (Figure 
R4). Previous studies found retention of dermal CD8 T cells within resolved lesions (Suárez-
Fariñas et al., 2011). While our result agreed with this (PAPER II, Supp. Figure 2), cytokine 
expression pattern found in the dermal T cells from resolved lesions was comparable to the 
healthy skin (PAPER II, Figure 5). These results revealed a population of CD8 T cells 
poised towards IL-17 production that resided in the epidermis of resolved lesions. 
 
Figure R4. IL-17 and IL-22 expression of epidermal T cells in resolved lesion 
(A-D) Proportion of IL-17A+ (A,B) or IL-22+ (C,D) cells among epidermal CD4 (A,C) or CD8 (B,D) T cells 
from healthy skin, resolved lesions treated with anti-TNF, anti-IL12/23 or nb-UVB, and active psoriasis lesions, 
upon PMA and ionomycin stimulation in the presence of Brefeldin A. Mann-Whitney U test against healthy 
control, corrected for multiple testing. * p<0.05, ** p<0.01.  (E) Representative contour plot of epidermal CD8 T 
cells showing IL-17A and CD49a expression. (F) Proportion of CD49a- and CD49a+ cells among IL-17A 
expressing epidermal CD8 T cells upon PMA and ionomycin stimulation. 
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A population of CD103+CCR6+IL-23R+ CD8 TRM cells was highly enriched in resolved 
psoriasis (PAPER II, Figure 6), and IL-17A production was mainly produced by 
CD8+CD103+CD49a- TRM cells (Figure R4, PAPER II, Figure 6). This finding echoed with 
the functional distinction between CD8+CD103+CD49a- TRM cells and CD8+CD103+CD49a+ 
TRM cells from healthy epidermis in which IL-17A was produced mainly by the 
CD8+CD103+CD49a- TRM cells (PAPER I). On the contrary, CD4 T cells in resolved 
epidermis did not show any preference for their IL-22 production regarding CD103 
expression (PAPER II, Supplemental Figure 3). Thus, the epidermis of resolved psoriasis 
lesions upon successful treatment contain resident T cells poised for IL-17A or IL-22 
expression, which are highly pathogenic cytokines in psoriasiform inflammation. We 
proposed that these pathogenic T cells resided in epidermis marked the region of previously 
inflamed skin and that their reactivation might lead to the relapse of psoriasis upon 
reactivation (PAPER II, Figure 7). 
7.7 Genetic Variant in IL22 Promoter Associates with Early Onset of 
Psoriasis 
IL-22 from T cells sustains both keratinocyte hyperproliferation and epidermal antimicrobial 
responses in different settings(Wolk et al., 2004; Eyerich et al., 2009; Nograles et al., 2009). 
Both CD4 and CD8 T cells expressed IL-22 in the lesional epidermis (PAPER II, Figure 
2,5). Besides, Th22 cells resided in resolved lesions of anti-TNF, anti-IL12/23p40, and UVB-
treated patients (PAPER II, Figure 5), but the inter-individual variation is high (Figure R4). 
The aryl hydrocarbon receptor (AHR) is a potent inducer of IL-22 response in CD4 T cells 
(Veldhoen et al., 2008). Through stratification strategy, we found that four genetic variants (3 
SNPs and one INDEL (insertion/deletion) on predicted AHR–ARNT binding sites of the 
IL22 promoter were associated with psoriasis with onset before ten years of age in two 
independent Swedish cohorts (PAPER IV, Figure 1 and Table 2). Haplotype analysis 
revealed that the haplotype with all minor alleles for the four variations resulted in an odds 
ratio of 3.80, and the homozygousity for all minor alleles conferred an odds ratio of 4.03. The 
risk genotype led to higher IL22 transcriptional activity (PAPER IV, Figure 2) and elevated 
IL-22 production from peripheral CD4 T cells in patients (PAPER IV, Figure 3). 
Specifically, these results identified a genetic association in patients with early onset of 
psoriasis that lead to higher expression of inflammatory cytokine related to the pathogenesis 
of psoriasis. 
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8 DISCUSSION 
The complex interaction between genetic heterogeneity and environmental differences 
introduces large variations among human subjects as evident in the genetic variant of the 
IL22 promoter that results in higher transcriptional activity and higher production of IL-22 
protein in CD4 T cells (PAPER IV). In this thesis, the functional heterogeneity of skin-
resident T cells was studied in the human system. The findings provided new insights into the 
role of TRM cell in skin immunology and dermatological diseases. At the same time, they 
have raised new questions to be further addressed. 
8.1 Localized Disease Memory of Resolved Psoriasis 
Relapsing psoriasis at the site of previous lesions upon treatment withdrawal is a major 
challenge when treating psoriasis (Clark, 2011). In PAPER II, we showed that pathogenic 
Th22 and Tc17 cells resided in successfully treated psoriasis lesions despite long-term 
clinical remission. Based on these results, we proposed a model of T-cell mediated localized 
disease memory in resolved psoriasis  (PAPER II, Figure 7). After successful treatment, the 
number of epidermal T cells was normalized but TRM cells retained pathogenic potential 
within the previous lesions. Upon reactivation, epidermal CD4 T cells and CD8 T cells 
responded with IL-22 and IL-17A production respectively. We proposed that the pathogenic 
cytokines produced by reactivated TRM cells would activate surrounding keratinocytes, 
amplify the localized inflammation and, subsequently, recruit inflammatory cells into the skin 
(Figure D1). This model provides a T cell-mediated mechanism on how psoriasis relapses at 
sites of previous lesions. 
 
Figure D1. A proposed model of localized disease memory in resolved psoriasis.  
In active psoriasis lesion, pathogenic T cells with high expression of IL-17 and IL-22 were enriched in the 
epidermis. Upon successful treatment, the number of T cells in skin is normalised but TRM cells retained 
pathogenic potential within the previous lesions. Upon reactivation, epidermal CD4 T cells respond with IL-22 
production and epidermal CD8 T cells with IL-17A production; thereby, activating surrounding keratinocytes, 
amplifying the localized inflammation and, subsequently, recruiting inflammatory cells in to the skin. PAPER II 
(Cheuk et al., 2014) 
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Whether pathogenic TRM cells remained in resolved epidermis were derived from the 
dominant clones during the active inflammation was not determined in PAPER II. Although 
oligoclonal expansion of T cells within psoriasis lesion has been reported (Chang et al., 1994; 
Lin et al., 2001), recent high-throughput TCR sequencing study suggested a rather polyclonal 
nature of T cell within the lesion (Harden et al., 2015a). Lately, LL-37 and melanocyte-
specific protein, ADAMTSL5, were proposed as autoantigens of psoriasis (Lande et al., 
2014; Arakawa et al., 2015). The identification of LL-37 as autoantigen was particularly 
interesting and whether elevated production of LL-37 by stressed keratinocytes could trigger 
pathogenic TRM cell reactivation warrants further investigation. However, a variety of 
autoantigens could exist among a heterogeneous population of patients. Therefore, regardless 
of which autoantigens the pathogenic TRM cells are recognizing, understanding the 
developmental pathway of pathogenic TRM cells is of great importance. It is equally important 
to investigate whether the pathogenic TRM cells have different survival mechanisms as 
compared to the protective TRM cells. In this case, it would be possible to specifically target 
the pathogenic TRM and to preserve the protective TRM cells, which would be of great 
therapeutic interest. 
8.2 Clinical Implications of the Presence of CD8+CD103+CD49a+ TRM Cells in 
Vitiligo  
CD8+CD103+CD49a+ TRM cells were highly enriched in both epidermis and dermis of the 
vitiligo lesions (PAPER I). Although the antigen-specificity of CD8+CD103+CD49a+ TRM 
cell from vitiligo lesion is not determined in PAPER I, previous studies showed that 
perilesional T cells from vitiligo were able to induce apoptosis in autologous melanocytes 
(van den Boorn et al., 2009; Wu et al., 2013). Therefore, it is likely that at least part of the 
CD8+CD103+CD49a+ TRM cells in vitiligo lesion could react to melanocyte-antigen. The 
epidermis of depigmented lesions lack melanocytes, but melanocytes can be preserved in hair 
follicles (Cui et al., 1991) and their precursors can be found in the dermis (Li et al., 2010). 
The presence of epidermal and dermal CD8+CD103+CD49a+ T cells co-expressing perforin 
and granzyme B may, therefore, prevent repopulation of melanocytes from the reservoir in 
hair follicles or dermis. Interestingly, in autologous melanocyte transplantation treatment, a 
high density of CD8 T cells within the lesion led to poor repigmentation while effective 
repigmentation was noticed in patients with few lesional CD8 T cells (Zhou et al., 2013). 
Therefore, the outcome of autologous melanocyte transplantation depends on the density of 
CD8 T cells within the lesion. Given the role of IL-15 in the cytotoxic function of TRM cells 
as illustrated in PAPER I, blocking of IL-15 signaling may be beneficial in vitiligo. 
Recently, a case study reported that treatment of Tofacitinib, which could antagonize 
JAK1/JAK3 mediated IFNs or IL-15 downstream signaling, resulted in significant 
repigmentation (Craiglow and King, 2015). Thus, the therapeutic effects of IL-15 signaling 
antagonist deserve further investigation. Also, relapses of vitiligo after treatment have been 
well documented (Shaffrali and Gawkrodger, 2000; Taieb et al., 2012) but whether the 
relapses mainly occur at previously depigmented regions is less characterized. Nonetheless, 
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the potential role of CD8+CD103+CD49a+ TRM cells in this relapse process would be 
interesting to investigate. 
8.3 Localized T Cell-mediated Immunologic Memory 
T cell-mediated immunity is characterized by specialization in effector functions. Indeed, the 
classification of immune response according to their cytokine production, functional 
properties, and surface marker expression – the “Subsetology”- has become a cornerstone in 
contemporary immunology research. From the classical distinctions between Th1 and Th2 
cells to the discovery of Th17 cells, research from the past decades showed that memory and 
effector T cells can be specialized in diverse immune responses. In addition to functional 
specialization, T cells can be recruited from the circulation to different tissues, and, thereafter, 
mediate localized cellular immunity. In this thesis, careful dissection of the resident T cell 
subpopulations in human skin provided further insights into their functional specialization. In 
PAPER I, functional distinctions of two epidermal CD8+ TRM cell subpopulations were 
revealed, in which CD8+CD103+CD49a+ TRM cells were highly poised towards IFN-γ and 
cytotoxic function, whereas CD8+CD103+CD49a- TRM cells preferentially produced IL-17. 
Such functional distinction was further illustrated in two common skin diseases with different 
pathogenic pathways. As shown in vitiligo, CD8+CD103+CD49a+ TRM cells were highly 
enriched in both epidermis and dermis of depigmented lesions, concurring the role of IFN-γ-
mediated inflammation and cellular cytotoxicity during the pathogenesis. In psoriasis, both 
CD4 and CD8 epidermal T cells display inflammatory gene signature and heighted IL-17 or 
Il-22 expression. Upon successful treatment, CD8+CD103+CD49a-TRM cells capable of 
producing IL-17 upon reactivation resided in resolved lesions (PAPER II). Together with 
epidermal CD4 capable of producing IL-22 upon restimulation, these TRM cells may form the 
cellular basis of the proposed molecular scar (Suárez-Fariñas et al., 2011), or “ localized 
disease memory” of psoriasis. 
 
Figure D2. Functional division of CD8+CD103+CD49a+/- TRM cells and their potential clinical relevance. 
(Left) Functional specialization of CD8+CD103+CD49a+ and CD8+CD103+CD49a- TRM cells in which 
CD8+CD103+CD49a+ TRM cells are highly poised towards IFN-γ production and cellular cytotoxicity, whereas 
CD8+CD103+CD49a- TRM cells are poised towards IL-17 production. (Right) Potential clinical relevance for 
CD8+CD103+CD49a+ and CD8+CD103+CD49a- TRM cells. 
Due to topological differences and the diversity of microenvironments, various areas of the 
skin are exposed to different pathogens and may be at risk of repeated immunological insults. 
Therefore, placing TRM cells with specialized functionality acquired from previous infections 
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or inflammations may be advantageous to contain or eradicate the repetitive immunologic 
challenge. In resolved viral infection in mice, TRM cells were poised to IFN-γ production that 
protected against re-infection (Schenkel et al., 2013; Ariotti et al., 2014; Schenkel et al., 
2014). Likewise, upon clinical remission of IL-17-medaited inflammation, TRM cells 
produced IL-17 production in response to restimulation (PAPER II). Thus, it is plausible that 
TRM cells are programmed and poised towards specific responses associated with the previous 
immunologic insults. In this regard, the high variation of CD49a+ TRM cells and the functional 
heterogeneity observed in PAPER I might reflect the complex history of the dermato-
immunological events experienced locally at the site of investigation. For instance, a higher 
frequency of CD49a+ TRM cells might imply a higher burden of previous anti-viral or cellular 
cytotoxicity response. In this context, it will be of great value to investigate how TRM cells 
with different functional capacities are generated by different infections and skin diseases. 
Repeated antigenic stimulation enhanced the size of circulating memory T cell pool and 
subsequent recall response through consecutive recall rechallenge in murine infection model 
(Vezys et al., 2009). Whether this is also true for the TRM cell population has not been 
determined. Of note, in murine models, there seems to be spatially limited epidermal niche 
for TRM cells (Zaid et al., 2014). This poses an interesting question on how multiple 
challenges from different pathogens over time changes the landscape of TRM cells regarding 
both the clonality and the functional specialization. Interestingly, as compared to HSV 
infection model (Gebhardt et al., 2009), vaccinia skin infection generates a globalized 
formation of TRM cells in skin epithelia during the primary effector phase  (Jiang et al., 2012). 
Further understanding of the underlying differences between these two models would provide 
valuable knowledge for vaccination program aiming at generating TRM at epithelial surfaces 
(Kupper, 2012). However, even in the vaccinia infection model, the number of virus-specific 
protective TRM cells is higher at the inoculation site as compared to the non-immunized sites, 
suggesting a quantitative difference. Through understanding how TRM cells are generated by 
various types of cutaneous inflammation, how different TRM subsets are formed and what the 
consequences of their reactivation are, the role of TRM cells in different disease contexts will 
be uncovered, and new therapeutic strategies could be identified. 
8.4 Potential Roles of CD49a+ TRM Cells in Anti-viral Protection, Tumor 
Surveillance and Anti-tumor Responses 
Both IFN-γ production and cellular cytotoxicity are crucial effector mechanisms of T cell-
mediated antiviral response. The skin is the target organ of common pathogenic viruses, such 
as HSVs, Human Papillomavirus, and Varicella zoster virus. TRM cells could provide 
localized defense and restrict viral propagation (Gebhardt et al., 2009; Jiang et al., 2012; 
Schenkel et al., 2014). In particular, CD8 TRM cells exert their protective role through 
multiple mechanisms: (1) recruitment of circulating memory T cells; (2) induction of DC 
maturation; (3) bystander activation of cytotoxic lymphocytes; (4) induction of local tissue 
inflammation and anti-viral response by IFN-γ (Schenkel et al., 2013; Ariotti et al., 2014; 
Schenkel et al., 2014). In PAPER I, functional and transcriptome data showed that 
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CD8+CD103+CD49a+ TRM cells in healthy human skin fulfilled such functional profile; in 
addition, a preferential cytotoxic function was confirmed in CD8+CD103+CD49a+ TRM cells 
derived from healthy skin. Ariotti et al argued that the local anti-viral inflammatory response 
induced by IFN-γ from antigen specific TRM cell was sufficient to control asymptomatic viral 
re-infection or reactivation, whereas the contribution of subsequent recruitment of circulating 
lymphocytes and the direct killing capacity of TRM cell might be limited (Ariotti et al., 2014). 
The first part of this argument is partially supported by Mackay el al where they showed that 
TRM cells could protect from reinfection even without the contribution of the recruitment of 
antigen specific circulating T cells (Mackay et al., 2015b). Although, the role of in situ 
cellular cytolysis is unclear, in previously HSV infected human genital skin, resident CD8 T 
cell expressed perforin protein during asymptomatic viral shedding suggesting a possible 
cytolytic contribution to clearance of virally infected cells (Zhu et al., 2013). Thus, it is 
highly plausible that effective TRM cell-mediated local defense requires the combination of 
IFN-γ and cytotoxic activity of TRM cells to constrain viral propagation and eradicate virally 
infected cells.  
The skin is an organ with constant intense cell division and the human epidermis is turned 
over every 40-56 days (Halprin, 1972). With the exposure to chemical, UVB and HPV, the 
risk of tumorigenesis in the skin increases with time (Melnikova and Ananthaswamy, 2005; 
Akgül et al., 2006). Indeed, skin cancers comprise some of the most prevalence forms of 
malignancy (Melnikova and Ananthaswamy, 2005). CD8 TRM cells are constantly crawling in 
the epidermis and can quickly recognize emergence of viral antigen (Ariotti et al., 2012; Zaid 
et al., 2014). In a similar manner, TRM cells may provide surveillance not only to pathogens 
but also to tumors. In physiological condition without prior priming to a tumor antigen, it is 
unlikely that TRM cells bearing TCR highly specific against tumor antigens would be 
stationed in the epithelia. Aside from the slight probability of cross-reactivity to tumor-
antigen with the limited TCR- repertoire placed in the skin, it is plausible that TRM cells may 
recognize tumor cells through antigen-independent mechanisms, e.g. NKG2D- mediated 
activation (Nausch and Cerwenka, 2008; Zhang et al., 2015), which has been reported in 
intraepithelial T cells in gut mucosa (Hüe et al.; Meresse et al., 2004). Indeed, cutaneous 
tumor surveillance by DETC in mouse has been shown to be NKG2D-dependent (Girardi et 
al., 2001). Therefore, it is possible that TRM cells can survey and contain initial tumorigenesis 
in epithelial layers. Alternatively, strategies generating tumor-specific TRM cells are worth 
exploring. 
CD8 T cell plays a significant role in anti-tumor immunity. The numbers of tumor-infiltrating 
CD8 T cells show good prognosis for the vast majority of cancers (Fridman et al., 2012). 
Tumor-infiltrating CD8 T cells shared the phenotypic characteristics of the TRM cells and it 
has been reported that, in ovarian, lung and bladder cancer, the density of CD103 expressing 
tumor-infiltrating CD8 T cells is strongly associated with patient survival rate (Webb et al., 
2014; Djenidi et al., 2015; Wang et al., 2015). In light of the highly specialized cytotoxic 
functions of the CD103+CD49a+ TRM cells in the epidermal tissue (PAPER I), it will be of 
great interest to determine whether tumor infiltrating T cells express CD49a and whether the 
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CD49a+ tumor infiltrating T cells provide better immune protection as compared to other 
CD8 T cell subpopulations. Interestingly, CD49a+ CD8 T cells have been identified in human 
mucosal tumors of epithelial origin, and CD49a blockade significantly reduced survival in a 
murine mucosa epithelial tumor model (Sandoval et al., 2013). If a similar pattern can be 
observed in other forms of malignancy, detailed knowledge on the generation and activation 
of CD49a+ TRM may improve the design of immunotherapies in the context of solid tumors. 
8.5 The Multifaceted Roles of IL-15 in TRM Generation, Homeostasis and 
Effector Functions 
PAPER I showed a critical role of IL-15 in augmenting TRM cell functions. Not only were 
IFN-γ production and cellular cytotoxicity strongly promoted in CD49a+ TRM cells by IL-15, 
but also IL-17A expression in CD49a- TRM cells  (PAPER I), suggesting a general role of IL-
15 in enhancing multiple TRM cell-mediated effector mechanisms. On the contrary, the blood-
borne effector-like CD57+ CD8 cells did not require IL-15 for their cytolytic activity (PAPER 
I, Figure 4). This highlighted the difference in the regulation of effector functions between 
tissue resident cells and circulating effector cells. Placing highly cytotoxic TRM cells at skin 
epithelium may potentially lead to unwanted tissue damage. In this regard, IL-15 may 
provide an extra layer of regulation in TRM cell function apart from the antigenic stimulation.   
Tissue stromal cells within the skin, including keratinocytes and fibroblasts, are able to 
produce IL-15 (Mohamadzadeh et al., 1995). Keratinocytes, especially those within hair 
follicles, constitutively express IL-15, potentially maintaining TRM cell homeostasis (Adachi 
et al., 2015). Expression of IL-15 and IL-15Rα in keratinocytes or epithelial cells can be 
elevated by interferon stimulation (Teunissen et al., 1998; Sanda et al., 2006). Also, it has 
been demonstrated that DCs and LCs could boost effector function or break T cell tolerance 
via IL-15 trans-presentation by IL-15Rα (McGill et al., 2010; Romano et al., 2012). Since 
TRM cell from healthy skin does not express perforin or granzyme prior to stimulation 
(PAPER I), the constitutive expression of IL-15 from keratinocyte is probably not sufficient 
to induce cytolytic protein expression in the CD8+CD103+CD49a+ TRM cells. It is, therefore, 
likely that the upregulation of granzymes and perforin in TRM cells in vivo requires a higher 
titer of IL-15 or trans-presentation of IL-15 by IL-15Rα (Figure D3). Since IL-15 provides 
both homeostatic and activating signals for TRM cells, misregulation of this delicate balance 
may cause pathology. Indeed, the role of IL-15 in skin diseases is well documented. Blocking 
of IL-15 in xenotransplant model dampened development of psoriasis (Villadsen et al., 2003) 
and stromal cell production of soluble IL-15Rα restricted psoriasiform inflammation 
(Bouchaud et al., 2013). Systemic blockade of IL-15Rβ prevented hair loss in an Alopecia 
areata mouse model of C3H/HeJ mice (Xing et al., 2014). On the other hand, IL-15 signaling 
agonists may be favorable for tumor therapy (Rosalia et al., 2014; Waldmann, 2015). Further 
understanding on how IL-15 regulates TRM cell homeostasis and function may lead to better 
modulation of their effector functions in different diseases. 
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Figure D3: Multifaceted roles of IL-15 in TRM cell biology.  
IL-15 is involved in TRM cell formation, survival and maintenance. Whether IL-15 also induces homeostatic 
proliferation of TRM cells in vivo is not clear. On the other hand (upper-right), IL-15 augments effector functions 
of TRM cells. These functions include IFN-γ and IL-17 production by different subsets of TRM, and upregulating 
cytotytic proteins in CD49a+, unleashing their cytotoxic potential. How these multifacet functions of IL-15 are 
regulated is unknown. We proposed that a higher concentration of IL-15 or trans-presentation by IL-15Rα is 
required for formation and effector function of TRM, whereas, lower concentration is sufficient for homeostatic 
survival of TRM. The differential stimulation between soluble IL-15 protein and trans-presentation by IL-15Rα 
deserves further investigation. 
8.6 Psoriasis – What is Happening in the Dermis?  
The functions of IL-17 and IL-22 have been highly implicated in the pathogenesis of 
psoriasis. We and others (Res et al., 2010) (PAPER II) showed that the proportion of 
epidermal T cells capable of producing IL-17 or IL-22 was larger than that in dermal T cells 
in active psoriasis lesion. Since epidermal T cells are in close contact with keratinocytes, the 
cytokines they produced would have a great impact on the keratinocyte pathology, which is 
one of the hallmarks of psoriasis pathology. Indeed, Conrad et al. showed infiltration of 
epidermal T cells is crucial for the development of psoriasis (Conrad et al., 2007).  
Dermal cells showed a relatively low proportion of pathogenic-cytokine expressing T cells 
and expressed lower level of inflammatory genes (Figure R3). Due to the increase of 
vasculatures in active psoriasis, it is possible that circulating nonpathogenic T cells are 
included in the dermal T cells of our analysis, diluting the proportion of cytokine-producing T 
cells. However, the increase in vasculatures is associated with the emergence of large clusters 
of T cells and dendritic cells in the dermis of the active lesions. It is possible that only T cells 
receiving sufficient activation in the dermal compartment migrate into epidermis, leading to 
the gene expression and cytokine production profile observed in PAPER II. In this regard, 
the relatively low proportion of pathogenic-cytokine producing T cells in dermis may reflect 
a delicate regulatory or selection mechanism. The landmark studies by Boyman et al. and 
Conrad et al. showed the local expansion and epidermal infiltration of T cells led to 
spontaneous development of psoriasis in previously uninvolved skin of psoriasis transplanted 
on AGR mice (Boyman et al., 2004; Conrad et al., 2007). In this model, dermal T cells 
expanded within a week of transplantation, preceding the increase in the number of epidermal 
T cells (Conrad et al., 2007), illustrating the expansion of dermal T cells before epidermal 
infiltration. In a recent report using the same model, proportion of IL-17 producing cells in 
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epidermal CD8 T cells was also significantly higher than the dermal CD8 T cells (Di Meglio 
et al., 2016); corroborating with our findings in an experimental setting. 
Laser capture microdissection microarray analysis revealed lymphoid tissue signature in these 
dermal inflammatory clusters of psoriasis (Mitsui et al., 2012). It was postulated that antigen 
presentation might take place in these clusters (Mitsui et al., 2012). Indeed, antigen 
presentation by dendritic cells in non-lymphoid tissue has been reported (Wakim et al., 2008; 
McLachlan et al., 2009; Macleod et al., 2014). During HSV murine skin infection, migration 
of LCs out of epidermis and accumulation of DCs in dermis were observed at the foci of 
infection sites (Eidsmo et al., 2009). Multiple DC subsets within infected skin were able to 
elicit CD4 T cell response (Macleod et al., 2014). In secondary lymphoid organs, weak TCR 
signal is enough for activation and generation of effector and memory cells, but a strong TCR 
signal is required for sustained expansion (Zehn et al., 2009). Therefore, secondary lymphoid 
organ selects the clone with the strongest TCR signals for expansion. Regarding cutaneous 
inflammation, it is plausible that the dermal T cell-DC clusters in psoriasis or the inducible 
Skin Associate Lymphoid Tissue (iSALT) structure, proposed by Kabashima and colleagues 
(Natsuaki et al., 2014), may serve as a local “selection” site in a similar manner that only the 
clone(s) with sufficient activation signals would infiltrate the epidermis.  
Taken the high prevalence of dermal inflammatory clusters in skin diseases, further 
understanding of this complex interaction between DCs and T cell in the dermis will be 
highly relevant for dermatology research. In delayed-type hypersensitivity reactions (DTH), 
Gaide et al. showed that hapten challenge to sensitized patients could lead to the formation of 
both TRM cell at the site of challenge as well as TCM cell in the circulation (Gaide et al., 2015). 
In a similar setting, Gulati et al. illustrated the formation of DC-T cell clusters within 3 days 
and peak at 14 days after challenge (Gulati et al., 2014). Taken together, the cellular process 
within inflammatory cluster may be involved in the generation of TRM cells. Spatial 
dissection of cellular process in sequential samples of DTH reactions will reveal dynamic 
process occurring in the clusters in the future. 
During skin infection, the up-regulation of adhesion molecules and chemokine recruits 
memory and effector T cells from the circulation; non-pathogen specific cells are also 
recruited into the tissue (Chapman et al., 2005; Ghani et al., 2009). Indeed, even naïve T cells 
can be recruited to non-lymphoid tissue during chronic inflammation (Weninger et al., 2003). 
It is, therefore, important to “select” the relevant clones to migrate to epidermis and fight 
pathogens. Misregulation of such “selection” process during infection may lead to epidermal 
infiltration and TRM formation of pathogenic T cell clones, potentially planting the seed for 
tissue autoimmunity or immune-mediated diseases. 
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9 CONCLUDING REMARKS 
TRM cells provide immune surveillance against pathogen re-infection but can also cause 
unwanted tissue inflammation and may lead to the local recurrence of immune-mediated skin 
diseases. In this thesis, I have summarized and discussed my work on the functional 
heterogeneity of skin resident T cells, in healthy skin and two different immune-mediated 
diseases, vitligo and psoriasis.  
The human skin contains heterogeneous populations of T cells. With a special emphasis on 
the CD8 T cells, a functional dichotomy of epidermal CD8 TRM cell in human skin was 
uncovered. CD8+CD103+CD49a+ TRM cells are highly poised towards IFN-γ production and 
cellular cytotoxicity. In healthy skin, CD8+CD103+CD49a+ TRM cells are relatively quiescent. 
IL-15 rapidly upregulates cytotoxic protein expression and unleashes efficient cytolytic 
killing capacity. In vitiligo, accumulation of perforin and granzyme B expressing 
CD8+CD103+CD49a+ TRM cells are enriched and accumulated in the depigmented lesions, 
potentially preventing repigmentation of the lesion (PAPER I). On the other hand, 
CD8+CD103+CD49a- TRM cells are poised towards IL-17 production in healthy skin (PAPER 
I). A similar CD8 TRM cell subpopulation, with heightened IL-17 producing capacity, reside 
in epidermis of resolved psoriasis lesion, together with CD4+ T cells preferentially expressing 
IL-22; thereby, forming a cellular basis for the proposed “localized disease memory” in 
resolved psoriasis (PAPER II).  
Taken together, the results presented in this thesis illustrate that the functional commitment of 
TRM cell resided in the tissue could be decided by the local history of the dermato-
immunological events, as exemplified by the CD8 TRM cells poised towards IL-17 production 
in resolved psoriasis. In order to provide a more comprehensive view on this concept, future 
studies should gather more data on the phenotypic and functional properties of TRM cells 
during active and resolved phases of various skin infections and inflammatory skin diseases 
while experimental models may further unravel the underlying mechanisms. What would be 
of most interest to me is to understand how consecutive local infections and inflammations 
shape or reshape the landscape of TRM cell population regarding both clonality and functional 
commitment. 
For therapeutic measures, TRM cell research offers a promising vaccination strategy to create 
a localized adaptive defence against pathogens. However, it is vital to understand and 
distinguish the developmental pathways of protective or pathogenic TRM cells, in order to 
minimize the possibility of detrimental tissue inflammation or autoimmunity. At the 
epidermal layer, malignancy poses a larger threat to human health than viral infection 
nowadays. I anticipate and hope that increasing knowledge in the functional regulation of 
TRM cells will provide new insight to improve current anti-tumor immunotherapies.  
Beside the main theme of the thesis, I have also explored an alternative effector mechanism 
of tissue resident T cells and determined the role of genetic control in T cell effector function. 
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These results broaden the scope of this thesis. PAPER III showed that granzyme A, highly 
expressed in lesional CD8 T cells in psoriasis, could enhance chemokine expression in 
inflamed keratinocytes, suggesting a potential inflammatory mechanism mediated by tissue-
resident T cells during chronic inflammation. PAPER IV demonstrated that a genetic variant 
of IL22 promoter associated with early onset of psoriasis confer increase IL22 transcriptional 
activity and IL-22 production in CD4 T cells, underscoring the impact of genetic 
heterogeneity on the susceptibility of human diseases. 
 
 An excerpt from the research proposal to the Croucher Foundation: 
“ Hypothesis: ....We proposed that pathogenic memory T cells reside in epidermis after 
acute/primary onset of psoriasis. Upon re-stimulation, these memory T cells will be activated 
in situ; thereby, giving rise to a local inflammatory response that further recruits immune 
cells to the lesion....” 
Stanley Cheuk, 2010 
Back in 2010, the concept of tissue resident memory T cell was still budding. I entered the 
field, full of enthusiasm, to study the role of skin resident T cells in human skin with the 
special focus on resolved lesions in psoriasis. The project was challenging and we didn’t 
know much about these cells in human skin. Five years later, different groups have confirmed 
the protective role of TRM cells in different murine models. During these exciting years in 
TRM cell research, much effort has been devoted to elucidating the formation, maintenance 
and effector mechanisms of TRM cells. In the same period, the role of TRM cells has been 
implicated in an increasing number of skin diseases in human. Hopefully, the data presented 
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